-
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Chemical research in toxicology 20150518
-
Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
Bioorganic & medicinal chemistry letters 20121201
-
Presence of oseltamivir-resistant pandemic A/H1N1 minor variants before drug therapy with subsequent selection and transmission.
The Journal of infectious diseases 20121115
-
Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection.
The Pediatric infectious disease journal 20121101
-
U.S. utilization patterns of influenza antiviral medications during the 2009 H1N1 influenza pandemic.
Influenza and other respiratory viruses 20121101
-
Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance.
International journal of antimicrobial agents 20121101
-
Exploring the interactions of unsaturated glucuronides with influenza virus sialidase.
Journal of medicinal chemistry 20121025
-
Molecular basis of drug resistance in A/H1N1 virus.
Journal of chemical information and modeling 20121022
-
A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase.
Chembiochem : a European journal of chemical biology 20121015
-
Enhanced anti-influenza agents conjugated with anti-inflammatory activity.
Journal of medicinal chemistry 20121011
-
Portable miniaturized extracorporeal membrane oxygenation systems for H1N1-related severe acute respiratory distress syndrome: a case series.
Journal of critical care 20121001
-
Rational development of neuraminidase inhibitor as novel anti-flu drug.
Mini reviews in medicinal chemistry 20121001
-
Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents.
Antiviral research 20121001
-
Aqueous normal phase liquid chromatography coupled with tandem time-of-flight quadrupole mass spectrometry for determination of zanamivir in human serum.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20121001
-
ACP Journal Club. Review: oseltamivir relieves symptoms but does not reduce hospitalizations in influenza.
Annals of internal medicine 20120918
-
Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
ChemMedChem 20120901
-
An uncontrolled open-label, multicenter study to monitor the antiviral activity and safety of inhaled zanamivir (as Rotadisk via Diskhaler device) among Chinese adolescents and adults with influenza-like illness.
Chinese medical journal 20120901
-
H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis.
PLoS pathogens 20120901
-
Understanding the interplay of weak forces in [3,3]-sigmatropic rearrangement for stereospecific synthesis of diamines.
Accounts of chemical research 20120821
-
Computational study on new natural polycyclic compounds of H1N1 influenza virus neuraminidase.
Journal of molecular modeling 20120801
-
A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120801
-
In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010-2011 season in Japan.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120801
-
In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir.
The Journal of antimicrobial chemotherapy 20120801
-
Oseltamivir-resistant 2009 H1N1 influenza pneumonia during therapy in a renal transplant recipient.
Pediatric transplantation 20120801
-
Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities.
European journal of medicinal chemistry 20120801
-
Quantitative predictions of binding free energy changes in drug-resistant influenza neuraminidase.
PLoS computational biology 20120801
-
Recent advances in the diagnosis and treatment of influenza pneumonia.
Current infectious disease reports 20120601
-
Effect of a single inhalation of laninamivir octanoate in children with influenza.
Pediatrics 20120601
-
Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
Biochemistry 20120529
-
Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia.
Emerging infectious diseases 20120501
-
Human infections with novel reassortant influenza A(H3N2)v viruses, United States, 2011.
Emerging infectious diseases 20120501
-
Origin of the inhibitory activity of 4-O-substituted sialic derivatives of human parainfluenza virus.
Glycoconjugate journal 20120501
-
Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).
The Cochrane database of systematic reviews 20120418
-
Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry.
Analytical chemistry 20120417
-
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.
Annals of internal medicine 20120403
-
Influenza virus resistance to neuraminidase inhibitors: implications for treatment.
Current infectious disease reports 20120401
-
Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): a multicenter study in Korea.
Journal of Korean medical science 20120401
-
A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon.
PLoS pathogens 20120401
-
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States.
Antiviral research 20120301
-
Rational approaches to improving selectivity in drug design.
Journal of medicinal chemistry 20120223
-
Catalytic asymmetric anti-selective nitroaldol reaction en route to zanamivir.
Angewandte Chemie (International ed. in English) 20120213
-
Neuraminidase inhibitor susceptibility of swine influenza A viruses isolated in Germany between 1981 and 2008.
Medical microbiology and immunology 20120201
-
Analysis of cases of severe respiratory failure in children with influenza (H1N1) 2009 infection in Japan.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120201
-
High and continuous exposure of laninamivir, an anti-influenza drug, may work suppressively to generate low-susceptibility mutants in animals.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20120201
-
Structure-based discovery of anti-influenza virus A compounds among medicines.
Biochimica et biophysica acta 20120201
-
Quantitative trace analysis of a broad range of antiviral drugs in poultry muscle using column-switch liquid chromatography coupled to tandem mass spectrometry.
Analytical and bioanalytical chemistry 20120201
-
Genomic signatures and antiviral drug susceptibility profile of A(H1N1)pdm09.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20120201
-
Synthesis and antiviral activities of novel gossypol derivatives.
Bioorganic & medicinal chemistry letters 20120201
-
Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.
Emerging infectious diseases 20120201
-
Characterization and long-term persistence of immune response following two doses of an AS03A-adjuvanted H1N1 influenza vaccine in healthy Japanese adults.
Human vaccines & immunotherapeutics 20120201
-
Neuraminidase inhibitors for preventing and treating influenza in children.
The Cochrane database of systematic reviews 20120118
-
Amantadine and rimantadine for influenza A in children and the elderly.
The Cochrane database of systematic reviews 20120118
-
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
The Cochrane database of systematic reviews 20120118
-
Antiviral drugs for influenza.
The Medical letter on drugs and therapeutics 20120109
-
3,4-Dicaffeoylquinic Acid, a Major Constituent of Brazilian Propolis, Increases TRAIL Expression and Extends the Lifetimes of Mice Infected with the Influenza A Virus.
Evidence-based complementary and alternative medicine : eCAM 20120101
-
Influenza neuraminidase: a druggable target for natural products.
Natural product reports 20120101
-
Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases.
Journal of biomedicine & biotechnology 20120101
-
Isolation, identification, and phylogenetic analysis of reassortant low-pathogenic avian influenza virus H3N1 from Pakistan.
Poultry science 20120101
-
[Influenza A, will it keep on mutating?].
Medicina intensiva 20120101
-
Inhaled nitric oxide therapy fails to improve outcome in experimental severe influenza.
International journal of medical sciences 20120101
-
Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses.
Emerging infectious diseases 20120101
-
Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California.
BMC public health 20120101
-
The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011.
BMC infectious diseases 20120101
-
Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses.
PloS one 20120101
-
Risk factors of household transmission of pandemic (H1N1) 2009 among patients treated with antivirals: a prospective study at a primary clinic in Japan.
PloS one 20120101
-
[Clinical trials and intensive therapy of the swine flu (H1N1)].
Georgian medical news 20120101
-
Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A(H1N1)pdm09 in Japan.
PloS one 20120101
-
Different inhibitory potency of febuxostat towards mammalian and bacterial xanthine oxidoreductases: insight from molecular dynamics.
Scientific reports 20120101
-
Computable features required to evaluate the efficacy of drugs and a universal algorithm to find optimally effective drug in a drug complex.
PloS one 20120101
-
Monoclonal antibodies targeting the synthetic peptide corresponding to the polybasic cleavage site on H5N1 influenza hemagglutinin.
Journal of biomedical science 20120101
-
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.
PloS one 20120101
-
An analysis of 332 fatalities infected with pandemic 2009 influenza A (H1N1) in Argentina.
PloS one 20120101
-
Exhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferret.
PloS one 20120101
-
Optimal design of intervention studies to prevent influenza in healthy cohorts.
PloS one 20120101
-
[Severe forms of influenza A (H1N1) 2009 in pregnant women: experience of the University Hospital of Fez, Morocco and literature review].
The Pan African medical journal 20120101
-
Clinical effectiveness of peramivir in comparison with other neuraminidase inhibitors in pediatric influenza patients.
International journal of pediatrics 20120101
-
Microfabricated engineered particle systems for respiratory drug delivery and other pharmaceutical applications.
Journal of drug delivery 20120101
-
The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
Methods in molecular biology (Clifton, N.J.) 20120101
-
The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors.
Methods in molecular biology (Clifton, N.J.) 20120101
-
The effect of rosuvastatin in a murine model of influenza A infection.
PloS one 20120101
-
Nationwide surveillance of influenza during the pandemic (2009-10) and post-pandemic (2010-11) periods in Taiwan.
PloS one 20120101
-
Maternal outcomes in critically ill obstetrics patients: A unique challenge.
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 20120101
-
Rescue of a H3N2 influenza virus containing a deficient neuraminidase protein by a hemagglutinin with a low receptor-binding affinity.
PloS one 20120101
-
Genome Stability of Pandemic Influenza A (H1N1) 2009 Based on Analysis of Hemagglutinin and Neuraminidase Genes.
The open virology journal 20120101
-
Combining molecular docking and molecular dynamics to predict the binding modes of flavonoid derivatives with the neuraminidase of the 2009 H1N1 influenza A virus.
International journal of molecular sciences 20120101
-
Viral infection in renal transplant recipients.
TheScientificWorldJournal 20120101
-
Eicosanoids and respiratory viral infection: coordinators of inflammation and potential therapeutic targets.
Mediators of inflammation 20120101
-
Adaptation of human parainfluenza virus to airway epithelium reveals fusion properties required for growth in host tissue.
mBio 20120101
-
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza A infection.
PloS one 20120101
-
The molecular mechanism of action of the CR6261-Azichromycin combination found through computational analysis.
PloS one 20120101
-
How to minimize the attack rate during multiple influenza outbreaks in a heterogeneous population.
PloS one 20120101
-
Secondary household transmission of 2009 pandemic influenza A (H1N1) virus among an urban and rural population in Kenya, 2009-2010.
PloS one 20120101
-
Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.
Antiviral therapy 20120101
-
I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y.
PloS one 20120101
-
Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed - a clinical, non-randomized study in children.
Forschende Komplementarmedizin (2006) 20120101
-
Exploring the mechanism of zanamivir resistance in a neuraminidase mutant: a molecular dynamics study.
PloS one 20120101
-
Supply of neuraminidase inhibitors related to reduced influenza A (H1N1) mortality during the 2009-2010 H1N1 pandemic: an ecological study.
PloS one 20120101
-
Bacterial neuraminidase rescues influenza virus replication from inhibition by a neuraminidase inhibitor.
PloS one 20120101
-
Potential of peptides as inhibitors and mimotopes: selection of carbohydrate-mimetic peptides from phage display libraries.
Journal of nucleic acids 20120101
-
Rationalizing tight ligand binding through cooperative interaction networks.
Journal of chemical information and modeling 20111227
-
Description of antiviral treatment among adults hospitalized with influenza before and during the 2009 pandemic: United States, 2005-2009.
The Journal of infectious diseases 20111215
-
Drugs: Lines of defence.
Nature 20111207
-
Enhancing the intestinal membrane permeability of zanamivir: a carrier mediated prodrug approach.
Molecular pharmaceutics 20111205
-
Serum KL-6 and surfactant protein D in children with 2009 pandemic H1N1 influenza infection.
Pediatrics international : official journal of the Japan Pediatric Society 20111201
-
The de-guanidinylated derivative of peramivir remains a potent inhibitor of influenza neuraminidase.
Bioorganic & medicinal chemistry letters 20111201
-
Role of permissive neuraminidase mutations in influenza A/Brisbane/59/2007-like (H1N1) viruses.
PLoS pathogens 20111201
-
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
PLoS computational biology 20111201
-
Virological surveillance and antiviral resistance of human influenza virus in Argentina, 2005-2008.
Revista panamericana de salud publica = Pan American journal of public health 20111201
-
Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers in South Apulia, Italy: a pilot study.
Journal of clinical medicine research 20111201
-
Antivirals and resistance: influenza virus.
Current opinion in virology 20111201
-
Preparation and evaluation of zanamivir-loaded solid lipid nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 20111130
-
A practical synthesis of zanamivir phosphonate congeners with potent anti-influenza activity.
Journal of the American Chemical Society 20111109
-
Antiviral treatment of influenza A (H1N1-09) guided by molecular resistance testing in aplasia after allo-SCT.
Bone marrow transplantation 20111101
-
Severe H1N1-infection during pregnancy.
Archives of gynecology and obstetrics 20111101
-
[Clinical features and contagiousness of influenza A(H1N1) in health care workers and hospitalized patients in a Mexico City hospital].
Enfermedades infecciosas y microbiologia clinica 20111101
-
Molecular dynamics directed CoMFA studies on carbocyclic neuraminidase inhibitors.
Molecular diversity 20111101
-
Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.
Clinical pharmacokinetics 20111101
-
Deaths associated with pandemic (H1N1) 2009 among children, Japan, 2009-2010.
Emerging infectious diseases 20111101
-
Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11.
Emerging infectious diseases 20111101
-
[Epidemiological study of clinical backgrounds of influenza patients in an open hospital of Yokohama City in the last ten years].
Rinsho byori. The Japanese journal of clinical pathology 20111101
-
Prospective of Genomics in Revealing Transmission, Reassortment and Evolution of Wildlife-Borne Avian Influenza A (H5N1) Viruses.
Current genomics 20111101
-
Correlation analyses on binding affinity of sialic acid analogues and anti-influenza drugs with human neuraminidase using ab initio MO calculations on their complex structures--LERE-QSAR analysis (IV).
Journal of chemical information and modeling 20111024
-
Prediction of zanamivir efficiency over the possible 2009 influenza A (H1N1) mutants by multiple molecular dynamics simulations and free energy calculations.
Journal of molecular modeling 20111001
-
Severe H1N1-associated acute respiratory failure in immunocompromised children.
Pediatric blood & cancer 20111001
-
Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
Pharmacoepidemiology and drug safety 20111001
-
3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
Bioorganic & medicinal chemistry letters 20111001
-
Widespread use of neuraminidase inhibitors in Japan.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20111001
-
Antiviral drugs for viruses other than human immunodeficiency virus.
Mayo Clinic proceedings 20111001
-
Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.
Expert review of anti-infective therapy 20111001
-
Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition.
PLoS pathogens 20111001
-
IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.
PLoS pathogens 20111001
-
In vitro selection of influenza B viruses with reduced sensitivity to neuraminidase inhibitors.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20110901
-
Online monitoring of flu in Belgium.
Influenza and other respiratory viruses 20110901
-
Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection.
The Journal of infectious diseases 20110901
-
Estimating effect of antiviral drug use during pandemic (H1N1) 2009 outbreak, United States.
Emerging infectious diseases 20110901
-
Increased extent of and risk factors for pandemic (H1N1) 2009 and seasonal influenza among children, Israel.
Emerging infectious diseases 20110901
-
Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets.
PLoS pathogens 20110901
-
Screening method for the analysis of antiviral drugs in poultry tissues using zwitterionic hydrophilic interaction liquid chromatography/tandem mass spectrometry.
Analytica chimica acta 20110826
-
Intramolecular ion-pair prodrugs of zanamivir and guanidino-oseltamivir.
Bioorganic & medicinal chemistry 20110815
-
Structure-based drug design of a new chemical class of small molecules active against influenza A nucleoprotein in vitro and in vivo.
PLoS currents 20110807
-
Comparison of the efficacies of amantadine treatment of swine-origin influenza virus A H1N1 and seasonal influenza H1N1 and H3N2 in Japan (2008-2009).
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20110801
-
Assessing the ecotoxicologic hazards of a pandemic influenza medical response.
Environmental health perspectives 20110801
-
Real-time estimation and prediction for pandemic A/H1N1(2009) in Japan.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20110801
-
Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients.
Haematologica 20110801
-
Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child.
Emerging infectious diseases 20110801
-
Influenza vaccination, diagnosis, and treatment in children.
Pediatric emergency care 20110801
-
Influenza: epidemiology, clinical features, therapy, and prevention.
Seminars in respiratory and critical care medicine 20110801
-
First Fatal Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Case in an Adult in Korea.
Chonnam medical journal 20110801
-
Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site network approach: the INSIGHT FLU 002 and FLU 003 studies.
Vaccine 20110722
-
Use of intravenous neuraminidase inhibitors during the 2009 pandemic: results from population-based surveillance.
JAMA 20110713
-
Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.
Biochemical and biophysical research communications 20110708
-
Characterization and in vitro evaluation of intestinal absorption of liposomes encapsulating zanamivir.
Current drug delivery 20110701
-
Failure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.
Scandinavian journal of infectious diseases 20110701
-
Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A.
Respiratory care 20110701
-
Computational analysis and modeling the effectiveness of 'Zanamivir' targeting neuraminidase protein in pandemic H1N1 strains.
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 20110701
-
Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors.
Antiviral research 20110701
-
Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay.
Journal of medical virology 20110701
-
Intravenous zanamivir in critically ill patients due to pandemic 2009 (H1N1) influenza A virus.
Singapore medical journal 20110701
-
Structural basis for Streptococcus pneumoniae NanA inhibition by influenza antivirals zanamivir and oseltamivir carboxylate.
Journal of molecular biology 20110617
-
Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20110609
-
Comparison of the clinical symptoms and the effectiveness of neuraminidase inhibitors for patients with pandemic influenza H1N1 2009 or seasonal H1N1 influenza in the 2007-2008 and 2008-2009 seasons.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20110601
-
Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System.
American journal of obstetrics and gynecology 20110601
-
Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
Antiviral research 20110601
-
Outcome of pandemic H1N1 pneumonia: clinical and radiological findings for severity assessment.
The Korean journal of internal medicine 20110601
-
Follow-up after acute respiratory distress syndrome caused by influenza a (H1N1) virus infection.
Clinics (Sao Paulo, Brazil) 20110601
-
Pandemic Influenza A (H1N1): knowledge among senior health workers at a secondary health care institution in Southwest, Nigeria.
African health sciences 20110601
-
[Influenza A, pregnancy and neuraminidase inhibitors].
Medicina clinica 20110528
-
Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity.
Thorax 20110501
-
Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes.
Bioorganic & medicinal chemistry 20110501
-
Combinations of protein-chemical complex structures reveal new targets for established drugs.
PLoS computational biology 20110501
-
[A case of corpus callosum splenium encephalopathy and 2009 influenza A/H1N1].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20110501
-
Shortening ventilatory support with a protocol based on daily extubation screening and noninvasive ventilation in selected patients.
Clinics (Sao Paulo, Brazil) 20110501
-
Electrostatic clustering and free energy calculations provide a foundation for protein design and optimization.
Annals of biomedical engineering 20110401
-
A prediction rule to identify severe cases among adult patients hospitalized with pandemic influenza A (H1N1) 2009.
Journal of Korean medical science 20110401
-
H275Y mutant pandemic (H1N1) 2009 virus in immunocompromised patients.
Emerging infectious diseases 20110401
-
Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir.
Vaccine 20110321
-
Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110315
-
Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus.
Journal of pharmaceutical sciences 20110301
-
Feasibility of diagnosing influenza within 24Â hours of symptom onset in children 1-3Â years of age.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20110301
-
Peri-operative novel 2009 H1N1 influenza virus infection successfully treated with oseltamivir and zanamivir in a lung transplant recipient.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20110301
-
Antivirals in treatment of H1N1 infection: are they really effective?
European journal of pediatrics 20110301
-
Neuraminidase-inhibitor resistance testing for pandemic influenza A (H1N1) 2009 in Ontario, Canada.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20110301
-
Monitoring and characterization of oseltamivir-resistant pandemic (H1N1) 2009 virus, Japan, 2009-2010.
Emerging infectious diseases 20110301
-
Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy.
Pediatric reports 20110224
-
Resistance to neuraminidase inhibitors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110215
-
Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110215
-
Assessment of the effects of renal impairment on the pharmacokinetic profile of laninamivir, a novel neuraminidase inhibitor, after a single inhaled dose of its Prodrug, CS-8958.
Journal of clinical pharmacology 20110201
-
Successful salvage therapy with inhaled zanamivir in a patient with peramivir-resistant pandemic influenza A (H1N1) 2009 virus.
Scandinavian journal of infectious diseases 20110201
-
Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20110201
-
Pooled human immunoglobulin therapy in critically Ill patients with pandemic 2009 influenza A(H1N1) pneumonitis and immunoglobulin G2 subclass (IgG2) deficiency.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110201
-
Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States.
Emerging infectious diseases 20110201
-
Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico.
Emerging infectious diseases 20110201
-
[Favorable outcome of acute respiratory failure caused by H1N1 virus infection in critical patients].
Revista espanola de anestesiologia y reanimacion 20110201
-
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 20110121
-
Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza.
PLoS currents 20110103
-
Top-hits for H1N1pdm Identified by Virtual Screening Using Ensemble-based Docking.
PLoS currents 20110103
-
Novel swine--origin influenza A: the 2009 H1N1 influenza virus.
Indian journal of pediatrics 20110101
-
Oseltamivir, zanamivir and amantadine in the prevention of influenza: a systematic review.
The Journal of infection 20110101
-
Potential of Complementary and Alternative Medicine in Preventive Management of Novel H1N1 Flu (Swine Flu) Pandemic: Thwarting Potential Disasters in the Bud.
Evidence-based complementary and alternative medicine : eCAM 20110101
-
Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
Antiviral research 20110101
-
Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.
The Journal of infectious diseases 20110101
-
Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
The Journal of infectious diseases 20110101
-
Intensive care unit admission for pandemic (H1N1) 2009, Reunion Island, 2009.
Emerging infectious diseases 20110101
-
The nonadaptive nature of the H1N1 2009 Swine Flu pandemic contrasts with the adaptive facilitation of transmission to a new host.
BMC evolutionary biology 20110101
-
Fatal cases of 2009 pandemic influenza A (H1N1) in Korea.
Journal of Korean medical science 20110101
-
Ventilatory and ECMO treatment of H1N1-induced severe respiratory failure: results of an Italian referral ECMO center.
BMC pulmonary medicine 20110101
-
Identification of critical residues of influenza neuraminidase in viral particle release.
Virology journal 20110101
-
Nationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2009.
PloS one 20110101
-
Quantification of the anti-influenza drug zanamivir in plasma using high-throughput HILIC-MS/MS.
Bioanalysis 20110101
-
Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds.
PloS one 20110101
-
Optimizing tactics for use of the U.S. antiviral strategic national stockpile for pandemic influenza.
PloS one 20110101
-
The Ras-PI3K signaling pathway is involved in clathrin-independent endocytosis and the internalization of influenza viruses.
PloS one 20110101
-
We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century.
BMC public health 20110101
-
Swine-origin influenza a outbreak 2009 at Shinshu University, Japan.
BMC public health 20110101
-
A generic system for the expression and purification of soluble and stable influenza neuraminidase.
PloS one 20110101
-
Diagnosis and antiviral intervention strategies for mitigating an influenza epidemic.
PloS one 20110101
-
Influenza A virus hemagglutinin antibody escape promotes neuraminidase antigenic variation and drug resistance.
PloS one 20110101
-
Virus-associated hemophagocytic syndrome as a major contributor to death in patients with 2009 influenza A (H1N1) infection.
Critical care (London, England) 20110101
-
Emergence and genetic variation of neuraminidase stalk deletions in avian influenza viruses.
PloS one 20110101
-
A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial.
Trials 20110101
-
The impact of pandemic influenza H1N1 on health-related quality of life: a prospective population-based study.
PloS one 20110101
-
[Effect of Zanamivir substance on infection induced by highly pathogenic avian influenza A/H5N1 in cell cultures].
Voprosy virusologii 20110101
-
[Information of the Center for Ecology and Epidemiology of Influenza, D. I. Ivanovsky Research Institute of Virology, Russian Academy of Medical Sciences, on the results of the 2009-2010 influenza and acute respiratory viral infection epidemic season (at week 40 of 2009 to week 22 of 2010) in the world and Russia].
Voprosy virusologii 20110101
-
Comparative evaluation of acute respiratory distress syndrome in patients with and without H1N1 infection at a tertiary care referral center.
Indian journal of anaesthesia 20110101
-
Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009.
BMC infectious diseases 20110101
-
Assessing the in vitro fitness of an oseltamivir-resistant seasonal A/H1N1 influenza strain using a mathematical model.
PloS one 20110101
-
Can antiviral drugs contain pandemic influenza transmission?
PloS one 20110101
-
Reassortment and mutations associated with emergence and spread of oseltamivir-resistant seasonal influenza A/H1N1 viruses in 2005-2009.
PloS one 20110101
-
Assessing secondary attack rates among household contacts at the beginning of the influenza A (H1N1) pandemic in Ontario, Canada, April-June 2009: a prospective, observational study.
BMC public health 20110101
-
Profiling the chlorogenic acids of Rudbeckia hirta, Helianthus tuberosus, Carlina acaulis and Symphyotrichum novae-angliae leaves by LC-MS(n).
Phytochemical analysis : PCA 20110101
-
Defective interfering virus protects elderly mice from influenza.
Virology journal 20110101
-
Predictors of the uptake of A (H1N1) influenza vaccine: findings from a population-based longitudinal study in Tokyo.
PloS one 20110101
-
The use of Twitter to track levels of disease activity and public concern in the U.S. during the influenza A H1N1 pandemic.
PloS one 20110101
-
Systematic review of influenza resistance to the neuraminidase inhibitors.
BMC infectious diseases 20110101
-
Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases.
PloS one 20110101
-
Duration of viral shedding in hospitalized patients infected with pandemic H1N1.
BMC infectious diseases 20110101
-
Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression.
PloS one 20110101
-
Phylogenetic analysis of an off-seasonal influenza virus A (H3N2) in Niigata, Japan, 2010.
Japanese journal of infectious diseases 20110101
-
Clinico-epidemiological features of the hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in Saurashtra region, India (September, 2009 to February, 2010).
Lung India : official organ of Indian Chest Society 20110101
-
An insight into the swine-influenza A (H1N1) virus infection in humans.
Lung India : official organ of Indian Chest Society 20110101
-
Household transmission of influenza (H1N1-2009) in Japan: age-specificity and reduction of household transmission risk by zanamivir treatment.
The Journal of international medical research 20110101
-
Long-term respiratory follow-up of H1N1 infection.
Virology journal 20110101
-
Adverse drug reaction profile of oseltamivir in Indian population: A prospective observational study.
Indian journal of pharmacology 20110101
-
Avian influenza viruses infect primary human bronchial epithelial cells unconstrained by sialic acid α2,3 residues.
PloS one 20110101
-
Rapid detection of the H275Y oseltamivir resistance mutation in influenza A/H1N1 2009 by single base pair RT-PCR and high-resolution melting.
PloS one 20110101
-
Unusual association of ST-T abnormalities, myocarditis and cardiomyopathy with H1N1 influenza in pregnancy: two case reports and review of the literature.
Journal of medical case reports 20110101
-
New respiratory viruses and the elderly.
The open respiratory medicine journal 20110101
-
Analysis of CDC social control measures using an agent-based simulation of an influenza epidemic in a city.
BMC infectious diseases 20110101
-
Adverse drug reaction profile of oseltamivir in children.
Journal of pharmacology & pharmacotherapeutics 20110101
-
[Etiotropic therapy of influenza: lessons from the last pandemic].
Vestnik Rossiiskoi akademii meditsinskikh nauk 20110101
-
Influenza-associated monophasic neuromyelitis optica.
Internal medicine (Tokyo, Japan) 20110101
-
Lysosome-associated membrane glycoprotein 3 is involved in influenza A virus replication in human lung epithelial (A549) cells.
Virology journal 20110101
-
Selection of predicted siRNA as potential antiviral therapeutic agent against influenza virus.
Bioinformation 20110101
-
Adenovirus-vectored drug-vaccine duo as a rapid-response tool for conferring seamless protection against influenza.
PloS one 20110101
-
Pregnancy and virologic response to antiretroviral therapy in South Africa.
PloS one 20110101
-
Synthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an example.
Virology journal 20110101
-
Novel antiviral activity of neuraminidase inhibitors against an avian influenza a virus.
Virology journal 20110101
-
Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses.
PloS one 20110101
-
Molecular basis of NDM-1, a new antibiotic resistance determinant.
PloS one 20110101
-
A molecular and antigenic survey of H5N1 highly pathogenic avian influenza virus isolates from smallholder duck farms in Central Java, Indonesia during 2007-2008.
Virology journal 20110101
-
Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards.
PloS one 20110101
-
Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitro.
PloS one 20110101
-
Evaluation of Cynanchum otophyllum glucan sulfate against human immunodeficiency virus and herpes simplex virus as a microbicide agent.
Indian journal of pharmacology 20110101
-
Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis.
PloS one 20110101
-
Antiviral activity and increased host defense against influenza infection elicited by the human cathelicidin LL-37.
PloS one 20110101
-
Application of different chemometric tools in QSAR study of azolo-adamantanes against influenza A virus.
Research in pharmaceutical sciences 20110101
-
The feasibility of age-specific travel restrictions during influenza pandemics.
Theoretical biology & medical modelling 20110101
-
Rapid and specific influenza virus detection by functionalized magnetic nanoparticles and mass spectrometry.
Journal of nanobiotechnology 20110101
-
Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method.
PloS one 20110101
-
Synthesis of an antiviral drug precursor from chitin using a saprophyte as a whole-cell catalyst.
Microbial cell factories 20110101
-
Oseltamivir and early deterioration leading to death: a proportional mortality study for 2009A/H1N1 influenza.
The International journal of risk & safety in medicine 20110101
-
Structural position correlation analysis (SPCA) for protein family.
PloS one 20110101
-
Oseltamivir prescription and regulatory actions vis-Ã -vis abnormal behavior risk in Japan: drug utilization study using a nationwide pharmacy database.
PloS one 20110101
-
Chinese herbal medicines for the treatment of type A H1N1 influenza: a systematic review of randomized controlled trials.
PloS one 20110101
-
Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein.
PloS one 20110101
-
Anti-influenza virus effect of aqueous extracts from dandelion.
Virology journal 20110101
-
[A prognostic model of the effect of the antiviral drug Relenza on the epidemic of A(H1N1)/2009 influenza].
Voprosy virusologii 20110101
-
Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin.
PloS one 20110101
-
Triple combination antiviral drug (TCAD) composed of amantadine, oseltamivir, and ribavirin impedes the selection of drug-resistant influenza A virus.
PloS one 20110101
-
Influenza A(H1N1) Oseltamivir Resistant Viruses in the Netherlands During the Winter 2007/2008.
The open virology journal 20110101
-
Bioactive constituents and medicinal importance of genus Alnus.
Pharmacognosy reviews 20110101
-
Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients.
Advances in virology 20110101
-
Acute encephalopathy in childhood associated with novel influenza a h1n1 virus infection: clinical and neuroimaging findings.
The Ulster medical journal 20110101
-
One-pot bio-synthesis: N-acetyl-D-neuraminic acid production by a powerful engineered whole-cell catalyst.
Scientific reports 20110101
-
Persistent oseltamivir-resistant pandemic influenza A/H1N1 infection in an adult with cystic fibrosis.
BMJ case reports 20110101
-
A Validated HPLC Method for Zanamivir and its Application to In vitro Permeability Study in Caco-2 Culture Model.
Indian journal of pharmaceutical sciences 20110101
-
Top leads for swine influenza A/H1N1 virus revealed by steered molecular dynamics approach.
Journal of chemical information and modeling 20101227
-
Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.
Bioorganic & medicinal chemistry letters 20101215
-
LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity.
Journal of leukocyte biology 20101201
-
Pandemic (H1N1) 2009 infection in patients with hematologic malignancy.
Emerging infectious diseases 20101201
-
Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.
Emerging infectious diseases 20101201
-
Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1).
Hong Kong medical journal = Xianggang yi xue za zhi 20101201
-
Participatory epidemiology: use of mobile phones for community-based health reporting.
PLoS medicine 20101201
-
The changing face of pediatric respiratory tract infections: how human metapneumovirus and human bocavirus fit into the overall etiology of respiratory tract infections in young children.
The Yale journal of biology and medicine 20101201
-
[Case of novel influenza A (H1N1) pneumonia with shrinkage of a pulmonary lesion].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20101201
-
Structural insights into substrate specificity in variants of N-acetylneuraminic Acid lyase produced by directed evolution.
Journal of molecular biology 20101119
-
Coupling the Petasis condensation to an iron(III) chloride-promoted cascade provides a short synthesis of Relenza congeners.
Organic letters 20101119
-
New stilbenoid with inhibitory activity on viral neuraminidases from Erythrina addisoniae.
Bioorganic & medicinal chemistry letters 20101115
-
Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20101115
-
Surfactant therapy and intravenous zanamivir in severe respiratory failure due to persistent influenza A/H1N1 2009 virus infection.
American journal of respiratory and critical care medicine 20101115
-
Clinical pharmacokinetics of laninamivir, a novel long-acting neuraminidase inhibitor, after single and multiple inhaled doses of its prodrug, CS-8958, in healthy male volunteers.
Journal of clinical pharmacology 20101101
-
Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
Antiviral research 20101101
-
Selection and viral load kinetics of an oseltamivir-resistant pandemic influenza A (H1N1) virus in an immunocompromised patient during treatment with neuraminidase inhibitors.
Diagnostic microbiology and infectious disease 20101101
-
Pandemic (H1N1) 2009 and oseltamivir resistance in hematology/oncology patients.
Emerging infectious diseases 20101101
-
Oseltamivir-resistant pandemic (H1N1) 2009 treated with nebulized zanamivir.
Emerging infectious diseases 20101101
-
The persistence of influenza infection.
Emerging infectious diseases 20101101
-
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial.
PLoS medicine 20101101
-
Prone position ventilation, recruitment maneuver and intravenous zanamivir in severe refractory hypoxemia caused by influenza A (H1N1).
Clinics (Sao Paulo, Brazil) 20101101
-
Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of virus-like particles.
Journal of medicinal chemistry 20101028
-
NNScore: a neural-network-based scoring function for the characterization of protein-ligand complexes.
Journal of chemical information and modeling 20101025
-
Reduced effectiveness of oseltamivir in children infected with oseltamivir-resistant influenza A (H1N1) viruses with His275Tyr mutation.
The Pediatric infectious disease journal 20101001
-
Influenza in the tropics.
Current opinion in infectious diseases 20101001
-
Antivirals for influenza: strategies for use in pediatrics.
Paediatric drugs 20101001
-
Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009.
Emerging infectious diseases 20101001
-
Reflections on pandemic (H1N1) 2009 and the international response.
PLoS medicine 20101001
-
Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry.
PLoS pathogens 20101001
-
[In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses].
The Japanese journal of antibiotics 20101001
-
Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective.
Viruses 20101001
-
Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus.
The New England journal of medicine 20100930
-
Influenza hemagglutinin and neuraminidase membrane glycoproteins.
The Journal of biological chemistry 20100910
-
Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses.
Journal of medicinal chemistry 20100909
-
Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model.
Antiviral research 20100901
-
Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009.
Emerging infectious diseases 20100901
-
Pandemic influenza A (H1N1) in pregnant women: impact of early diagnosis and antiviral treatment.
Expert review of anti-infective therapy 20100901
-
[History of pandemic influenza in Japan].
Nihon rinsho. Japanese journal of clinical medicine 20100901
-
[Change of strategies for novel and seasonal flu during pregnancy].
Nihon rinsho. Japanese journal of clinical medicine 20100901
-
[Current anti-influenza virus chemotherapy].
Nihon rinsho. Japanese journal of clinical medicine 20100901
-
[Present and future in development of new anti-influenza drugs].
Nihon rinsho. Japanese journal of clinical medicine 20100901
-
[How have we understood and responded clinically to pandemic H1N1 2009?].
Nihon rinsho. Japanese journal of clinical medicine 20100901
-
[Influenza A/H1N1v 2009 during pregnancy and breastfeeding: which antiviral to choose?].
Annales pharmaceutiques francaises 20100901
-
Treatment options for H5N1: lessons learned from the H1N1 pandemic.
Postgraduate medicine 20100901
-
Molecular dynamics simulations suggest that electrostatic funnel directs binding of Tamiflu to influenza N1 neuraminidases.
PLoS computational biology 20100901
-
[Influenza A H1N1v treated with extracorporeal membrane oxygenation].
Ugeskrift for laeger 20100823
-
[Naturally occurring oseltamivir resistance in influenza A].
Ugeskrift for laeger 20100809
-
Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir.
Molecular pharmaceutics 20100802
-
Neuraminidase inhibitors for influenza treatment and prevention in healthy adults.
American family physician 20100801
-
Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
PLoS pathogens 20100801
-
Understanding the Influenza A H1N1 2009 Pandemic.
Sultan Qaboos University medical journal 20100801
-
Combination chemotherapy for influenza.
Viruses 20100801
-
Antiviral strategies for pandemic and seasonal influenza.
Viruses 20100801
-
Drugs in development for influenza.
Drugs 20100730
-
Severe H1N1 infection in a pediatric liver transplant recipient treated with intravenous zanamivir: efficiency and complications.
Transplantation 20100727
-
A medicinal chemist's guide to molecular interactions.
Journal of medicinal chemistry 20100722
-
[Impact of avian influenza virus H5N1 neuraminidase mutations on the activity of neuraminidase and the sensibility to neuraminidase inhibitors].
Zhonghua yi xue za zhi 20100720
-
Antiviral drug susceptibilities of seasonal human influenza viruses in Lebanon, 2008-09 season.
Journal of medical virology 20100701
-
Fatal respiratory events caused by zanamivir nebulization.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100701
-
Biotechnological production and applications of N-acetyl-D-neuraminic acid: current state and perspectives.
Applied microbiology and biotechnology 20100701
-
An unusual cause of fever in a neonate: influenza A (H1N1) virus pneumonia.
Pediatric pulmonology 20100701
-
Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.
Emerging infectious diseases 20100701
-
Oseltamivir-resistant pandemic (H1N1) 2009 in patient with impaired immune system.
Emerging infectious diseases 20100701
-
Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets.
PLoS pathogens 20100701
-
Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets.
PLoS pathogens 20100701
-
siRNA for Influenza Therapy.
Viruses 20100701
-
In silico identification of the potential drug resistance sites over 2009 influenza A (H1N1) virus neuraminidase.
Molecular pharmaceutics 20100607
-
Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy.
Recent patents on anti-infective drug discovery 20100601
-
Targeting pandemic influenza: a primer on influenza antivirals and drug resistance.
The Journal of antimicrobial chemotherapy 20100601
-
Use of intravenous zanamivir after development of oseltamivir resistance in a critically Ill immunosuppressed child infected with 2009 pandemic influenza A (H1N1) virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100601
-
Analogs of zanamivir with modified C4-substituents as the inhibitors against the group-1 neuraminidases of influenza viruses.
Bioorganic & medicinal chemistry 20100601
-
Reversible splenial lesion associated with novel influenza A (H1N1) viral infection.
Pediatric neurology 20100601
-
Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan.
Emerging infectious diseases 20100601
-
Peramivir and its use in H1N1 influenza.
Drugs of today (Barcelona, Spain : 1998) 20100601
-
Influenza A(H1N1) outbreak in a long-term care facility for severely handicapped residents, Slovenia, March-April 2009.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20100527
-
Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100501
-
Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.
The Journal of infectious diseases 20100501
-
Intravenous zanamivir for patients with pneumonitis due to pandemic (H1N1) 2009 influenza virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100501
-
Influenza outbreaks during World Youth Day 2008 mass gathering.
Emerging infectious diseases 20100501
-
Possible transmission of pandemic (HIN1) 2009 virus with oseltamivir resistance.
Emerging infectious diseases 20100501
-
Early pandemic influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: a clinical virological and epidemiological analysis.
PLoS medicine 20100501
-
Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of clade 2.2 A/Turkey/15/06 (H5N1) influenza virus in ferrets.
PLoS pathogens 20100501
-
Influenza: a virus of our times.
The Ulster medical journal 20100501
-
Complexity in influenza virus targeted drug design: interaction with human sialidases.
Journal of medicinal chemistry 20100408
-
The use of antiviral agents for the management of severe influenza.
Critical care medicine 20100401
-
Clinical management of pandemic 2009 influenza A(H1N1) infection.
Chest 20100401
-
Influenza A/H1N1 (2009) infection in pregnancy--an Asian perspective.
BJOG : an international journal of obstetrics and gynaecology 20100401
-
Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.
The Journal of antimicrobial chemotherapy 20100401
-
Oseltamivir in human avian influenza infection.
The Journal of antimicrobial chemotherapy 20100401
-
Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience.
The Journal of antimicrobial chemotherapy 20100401
-
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.
The Journal of antimicrobial chemotherapy 20100401
-
A close-up view of flu.
The Nurse practitioner 20100401
-
[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
Pathologie-biologie 20100401
-
Household transmission of pandemic (H1N1) 2009, San Antonio, Texas, USA, April-May 2009.
Emerging infectious diseases 20100401
-
Rapid emergence of oseltamivir resistance.
Emerging infectious diseases 20100401
-
Safety and immunogenicity of influenza A H1N1 vaccines.
Expert review of vaccines 20100401
-
Laboratory capacity building in Asia for infectious disease research: experiences from the South East Asia Infectious Disease Clinical Research Network (SEAICRN).
PLoS medicine 20100401
-
Mismatch primer-based PCR reveals that helicase-primase inhibitor resistance mutations pre-exist in herpes simplex virus type 1 clinical isolates and are not induced during incubation with the inhibitor.
The Journal of antimicrobial chemotherapy 20100401
-
Cancer screening and preventative care among long-term cancer survivors in the United Kingdom.
British journal of cancer 20100330
-
Neuraminidase inhibitors for the treatment of influenza infection in people with cystic fibrosis.
The Cochrane database of systematic reviews 20100317
-
An efficient method for N-acetyl-D-neuraminic acid production using coupled bacterial cells with a safe temperature-induced system.
Applied microbiology and biotechnology 20100301
-
Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.
Biophysical chemistry 20100301
-
Clinical presentation and response to treatment of novel influenza A H1N1 in a university-based summer camp population.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20100301
-
Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats.
Xenobiotica; the fate of foreign compounds in biological systems 20100301
-
Rare influenza A (H3N2) variants with reduced sensitivity to antiviral drugs.
Emerging infectious diseases 20100301
-
Neurologic manifestations of pandemic (H1N1) 2009 virus infection.
Emerging infectious diseases 20100301
-
[Influenza A (H1N1): clinical manifestations and prophylactic and therapeutic indications].
Archivos de bronconeumologia 20100301
-
[Clinical review of 1,017 influenza A cases between weeks 30 and 35 weeks in 2009].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20100301
-
[Research progress of anti-influenza virus agents].
Yao xue xue bao = Acta pharmaceutica Sinica 20100301
-
Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives.
Journal of medicinal chemistry 20100225
-
Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
The Cochrane database of systematic reviews 20100217
-
Fatal respiratory events caused by zanamivir nebulization.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20100215
-
Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing.
Antiviral research 20100201
-
Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
Antiviral research 20100201
-
Bifunctional polymeric inhibitors of human influenza A viruses.
Pharmaceutical research 20100201
-
Anti-influenza diarylheptanoids from the bark of Alnus japonica.
Bioorganic & medicinal chemistry letters 20100201
-
Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1).
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20100201
-
Oseltamivir-resistant pandemic (H1N1) 2009 influenza in a severely ill patient: the first Australian case.
The Medical journal of Australia 20100201
-
Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses.
PLoS pathogens 20100201
-
Glycosidase inhibition: assessing mimicry of the transition state.
Organic & biomolecular chemistry 20100121
-
[Controversies about neuraminidase inhibitor. Is the influenza drug less effective than assumed?].
MMW Fortschritte der Medizin 20100121
-
Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza.
The New England journal of medicine 20100107
-
Successful applications of computer aided drug discovery: moving drugs from concept to the clinic.
Current topics in medicinal chemistry 20100101
-
H1N1 influenza in pregnancy: cause for concern.
Obstetrics and gynecology 20100101
-
Oseltamivir- and amantadine-resistant influenza virus A (H1N1).
Emerging infectious diseases 20100101
-
Pandemic (H1N1) 2009 reinfection, Chile.
Emerging infectious diseases 20100101
-
Oseltamivir carboxylate, the active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan.
Environmental health perspectives 20100101
-
The truth about Tamiflu? Zanamivir should be inhaled, not nebulised.
BMJ (Clinical research ed.) 20100101
-
The first influenza pandemic of the 21st century.
Annals of Saudi medicine 20100101
-
Tamiflu: what dermatologists need to know.
Journal of drugs in dermatology : JDD 20100101
-
Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 season.
PloS one 20100101
-
Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants.
PloS one 20100101
-
New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets.
PloS one 20100101
-
Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidase.
BMC structural biology 20100101
-
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.
Journal of biomedical science 20100101
-
Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro.
PloS one 20100101
-
Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages.
International journal of health geographics 20100101
-
Avian influenza--a review for doctors in travel medicine.
Travel medicine and infectious disease 20100101
-
A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.
Virology journal 20100101
-
Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa.
BMC infectious diseases 20100101
-
Genomic signature and mutation trend analysis of pandemic (H1N1) 2009 influenza A virus.
PloS one 20100101
-
Genetic characterization of the influenza A pandemic (H1N1) 2009 virus isolates from India.
PloS one 20100101
-
Behavioural intentions in response to an influenza pandemic.
BMC public health 20100101
-
Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.
PloS one 20100101
-
Current advances in anti-influenza therapy.
Current medicinal chemistry 20100101
-
Bench-to-bedside review: bacterial pneumonia with influenza - pathogenesis and clinical implications.
Critical care (London, England) 20100101
-
[Fatal pneumonitis due to oseltamivir-resistant new influenza A(H1N1) in the case of an intensive care patient].
Nederlands tijdschrift voor geneeskunde 20100101
-
5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.
Virology journal 20100101
-
Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support.
PloS one 20100101
-
Co-lethality studied as an asset against viral drug escape: the HIV protease case.
Biology direct 20100101
-
To test or to treat? An analysis of influenza testing and antiviral treatment strategies using economic computer modeling.
PloS one 20100101
-
OpenFluDB, a database for human and animal influenza virus.
Database : the journal of biological databases and curation 20100101
-
Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009.
BMC infectious diseases 20100101
-
Optimized hydrophobic interactions and hydrogen bonding at the target-ligand interface leads the pathways of drug-designing.
PloS one 20100101
-
Molecular characteristics of the human pandemic influenza A virus (H1N1).
Acta virologica 20100101
-
Neuraminidase inhibitors for influenza in healthy adults: what we don't know.
The National medical journal of India 20100101
-
In Vitro Susceptibility of Canine Influenza A (H3N8) Virus to Nitazoxanide and Tizoxanide.
Veterinary medicine international 20100101
-
ETM-ANN approach application for thiobenzamide and quinolizidine derivatives.
Journal of biomedicine & biotechnology 20100101
-
Issues in pharmacotherapy of 2009 H1N1 influenza infection.
Journal of postgraduate medicine 20100101
-
Q&A: H1N1 pandemic influenza--what's new?
BMC biology 20100101
-
N-acetylglucosamine: production and applications.
Marine drugs 20100101
-
Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients.
PloS one 20100101
-
French experience of 2009 A/H1N1v influenza in pregnant women.
PloS one 20100101
-
Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in an university hospital of Morocco.
International archives of medicine 20100101
-
Prevention and treatment of influenza with hyperimmune bovine colostrum antibody.
PloS one 20100101
-
Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission.
PloS one 20100101
-
In vitro inhibitory activity of Alpinia katsumadai extracts against influenza virus infection and hemagglutination.
Virology journal 20100101
-
Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population.
Virology journal 20100101
-
Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling.
PloS one 20100101
-
Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza.
Antiviral chemistry & chemotherapy 20100101
-
Exploring cell tropism as a possible contributor to influenza infection severity.
PloS one 20100101
-
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro.
Antiviral therapy 20100101
-
The low-pH stability discovered in neuraminidase of 1918 pandemic influenza A virus enhances virus replication.
PloS one 20100101
-
H1N1pdm influenza infection in hospitalized cancer patients: clinical evolution and viral analysis.
PloS one 20100101
-
Iota-carrageenan is a potent inhibitor of influenza A virus infection.
PloS one 20100101
-
Influenza pandemic waves under various mitigation strategies with 2009 H1N1 as a case study.
PloS one 20100101
-
Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO.
Critical care research and practice 20100101
-
Correlates of severe disease in patients admitted with 2009 pandemic influenza A (H1N1) infection in Saurashtra region, India.
Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine 20100101
-
Strategies for the use of oseltamivir and zanamivir during pandemic outbreaks.
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 20100101
-
[Sensitivity of the epidemic and pandemic influenza virus strains to zanamivir (Relenze) in in vitro experiments].
Voprosy virusologii 20100101
-
Encephalitis in a child with H1N1 infection: First case report from India.
Journal of pediatric neurosciences 20100101
-
Computer-based de novo designs of tripeptides as novel neuraminidase inhibitors.
International journal of molecular sciences 20100101
-
Adamantane resistance in seasonal human influenza A viruses from Calgary, Alberta (January 2007 to August 2008).
The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 20100101
-
Zanamivir for the treatment of avian influenza infections in humans.
Expert review of clinical pharmacology 20100101
-
Effects of (L)-cystine and (L)-theanine supplementation on the common cold: a randomized, double-blind, and placebo-controlled trial.
Journal of amino acids 20100101
-
What Every Cardiologist Should Know about H1N1?
ARYA atherosclerosis 20100101
-
Epidemiological characteristics and low case fatality rate of pandemic (H1N1) 2009 in Japan.
PLoS currents 20091228
-
Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091215
-
Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase.
Glycoconjugate journal 20091201
-
[Pandemic influenza A H1N1 2009 flu during pregnancy: Epidemiology, diagnosis and management].
Journal de gynecologie, obstetrique et biologie de la reproduction 20091201
-
Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China.
Emerging infectious diseases 20091201
-
Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008.
Emerging infectious diseases 20091201
-
Antiviral treatment and prophylaxis of influenza virus in children.
Pediatric annals 20091201
-
Use of oseltamivir in children.
Canadian family physician Medecin de famille canadien 20091201
-
Pandemic influenza H1N1 2009, innate immunity, and the impact of immunosenescence on influenza vaccine.
The Yale journal of biology and medicine 20091201
-
Broad and potent anti-influenza virus spectrum of epigallocatechin-3-O-gallate-monopalmitate.
Journal of molecular and genetic medicine : an international journal of biomedical research 20091201
-
H1N1 influenza in pregnancy: risks, vaccines, and antivirals.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC 20091201
-
A(H5N1) Virus Evolution in South East Asia.
Viruses 20091201
-
In silico genome analysis and drug efficacy test of influenza A virus (H1N1) 2009.
Indian journal of microbiology 20091201
-
Efficacy of neuraminidase (NA) inhibitors against H1N1 strains of different geographical regions: an in silico approach.
Indian journal of microbiology 20091201
-
Predispensing of antivirals to high-risk individuals in an influenza pandemic.
PLoS currents 20091112
-
Optimizing tactics for use of the U.S. Antiviral Strategic National Stockpile for Pandemic (H1N1) Influenza, 2009.
PLoS currents 20091104
-
Antiviral drugs for treatment of patients infected with pandemic (H1N1) 2009 virus.
Emerging infectious diseases 20091101
-
Antiviral drugs for the treatment of influenza: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 20091101
-
Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: clinical and economic impact.
PLoS currents 20091027
-
Structural basis for oseltamivir resistance of influenza viruses.
Vaccine 20091023
-
Systematic review: safety and efficacy of extended-duration antiviral chemoprophylaxis against pandemic and seasonal influenza.
Annals of internal medicine 20091006
-
Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)?
Cell research 20091001
-
Dynamic behavior of avian influenza A virus neuraminidase subtype H5N1 in complex with oseltamivir, zanamivir, peramivir, and their phosphonate analogues.
Journal of chemical information and modeling 20091001
-
Guidelines on management of human infection with the novel virus influenza A (H1N1)--a report from the Hospital das ClÃnicas of the University of São Paulo.
Clinics (Sao Paulo, Brazil) 20091001
-
A model-based assessment of oseltamivir prophylaxis strategies to prevent influenza in nursing homes.
Emerging infectious diseases 20091001
-
Maximizing the value of drug stockpiles for pandemic influenza.
Emerging infectious diseases 20091001
-
SeqMonitor: influenza analysis pipeline and visualization.
PLoS currents 20090922
-
H1N1 pneumonitis treated with intravenous zanamivir.
Lancet (London, England) 20090919
-
Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
MMWR. Morbidity and mortality weekly report 20090911
-
[Disease caused by the new influenza A(H1N1) virus].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20090910
-
Synthetic approaches to the neuraminidase inhibitors zanamivir (Relenza) and oseltamivir phosphate (Tamiflu) for the treatment of influenza.
Chemical reviews 20090901
-
Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008.
Antiviral research 20090901
-
Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis.
The Lancet. Infectious diseases 20090901
-
Brief overview of bioinformatics activities in Singapore.
PLoS computational biology 20090901
-
Genomic diversity of oseltamivir-resistant influenza virus A (H1N1), Luxembourg, 2007-08.
Emerging infectious diseases 20090901
-
[Research progress of neuraminidase inhibitors for anti-influenza].
Yao xue xue bao = Acta pharmaceutica Sinica 20090901
-
Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Biochemical and biophysical research communications 20090828
-
Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.
MMWR. Morbidity and mortality weekly report 20090821
-
Synergistic effect of zanamivir-porphyrin conjugates on inhibition of neuraminidase and inactivation of influenza virus.
Journal of medicinal chemistry 20090813
-
Apropos 'vaccines in a hurry'.
Vaccine 20090806
-
Summary of the Australasian Society for Infectious Diseases and the Thoracic Society of Australia and New Zealand guidelines: treatment and prevention of H1N1 influenza 09 (human swine influenza) with antiviral agents.
The Medical journal of Australia 20090803
-
Oseltamivir resistance in swine influenza: a brief discussion.
North American journal of medical sciences 20090801
-
Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20090723
-
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090707
-
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
Antiviral research 20090701
-
Swine influenza: nephrologist's perspective.
Iranian journal of kidney diseases 20090701
-
[The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run].
Lakartidningen 20090701
-
Influenza virus neuraminidase: structure and function.
Acta naturae 20090701
-
Efficient method for the preparation of peracetylated Neu5Ac2en by flash vacuum pyrolysis.
The Journal of organic chemistry 20090605
-
Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en.
Bioorganic & medicinal chemistry letters 20090601
-
Emerging antiviral targets for influenza A virus.
Trends in pharmacological sciences 20090601
-
Reducing the burden of influenza-associated complications with antiviral therapy.
Infection 20090601
-
Basic rules of influenza: how to combat the H1N1 influenza (swine flu) virus.
American family physician 20090601
-
Telephone triage of patients with influenza.
American family physician 20090601
-
Past, present, and possible future human infection with influenza virus A subtype H7.
Emerging infectious diseases 20090601
-
FDA notifications. EUA issued for treating novel 2009 H1N1 flu.
AIDS alert 20090601
-
What is the optimal therapy for patients with H5N1 influenza?
PLoS medicine 20090601
-
Can we 'hedge' against the development of antiviral resistance among pandemic influenza viruses?
PLoS medicine 20090601
-
Sialic acid: a preventable signal for pneumococcal biofilm formation, colonization, and invasion of the host.
The Journal of infectious diseases 20090515
-
Novel influenza A (H1N1) virus infections in three pregnant women - United States, April-May 2009.
MMWR. Morbidity and mortality weekly report 20090515
-
A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
Journal of medicinal chemistry 20090514
-
Swine flu outbreak. What role for antiviral drugs?
Science (New York, N.Y.) 20090508
-
How severe will the flu outbreak be?
Nature 20090507
-
[Inquired of the President of the.Robert Koch Institute. How dangerous is Mexican influenza?].
MMW Fortschritte der Medizin 20090507
-
Update: infections with a swine-origin influenza A (H1N1) virus--United States and other countries, April 28, 2009.
MMWR. Morbidity and mortality weekly report 20090501
-
Update: drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009.
MMWR. Morbidity and mortality weekly report 20090501
-
Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
PLoS medicine 20090501
-
Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design.
Medicinal chemistry (Shariqah (United Arab Emirates)) 20090501
-
Seasonal influenza surveillance using prescription data for anti-influenza medications.
Japanese journal of infectious diseases 20090501
-
Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090401
-
Computational studies of H5N1 influenza virus resistance to oseltamivir.
Protein science : a publication of the Protein Society 20090401
-
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.
Emerging infectious diseases 20090401
-
Different neuraminidase inhibitor susceptibilities of human H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany from 2001 to 2005/2006.
Antiviral research 20090401
-
Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
JAMA 20090311
-
Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.
Journal of pharmaceutical sciences 20090301
-
[Validity in estimating influenza patient numbers from National Epidemiological Survey of Infectious Diseases (NESID) data using Oseltamivir consumption in Hyogo Prefecture].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20090301
-
Probing molecular level interaction of oseltamivir with H5N1-NA and model membranes by molecular docking, multinuclear NMR and DSC methods.
Biochimica et biophysica acta 20090201
-
Neuropsychiatric concerns related to influenza treatment.
The Nurse practitioner 20090201
-
Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08.
Emerging infectious diseases 20090201
-
Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 20090201
-
Antiviral resistance of influenza A (H3N2) strains isolated in northern Greece between 2004 and 2007.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20090129
-
Anti-influenza drugs: the development of sialidase inhibitors.
Handbook of experimental pharmacology 20090101
-
Developing new antiviral agents for influenza treatment: what does the future hold?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090101
-
Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005.
Emerging infectious diseases 20090101
-
Augmented lung inflammation protects against influenza A pneumonia.
PloS one 20090101
-
Threat of an influenza pandemic: family physicians in the front line.
BMC family practice 20090101
-
Molecular characterization of highly pathogenic H5N1 avian influenza A viruses isolated from raccoon dogs in China.
PloS one 20090101
-
Influenza virus antigenic variation, host antibody production and new approach to control epidemics.
Virology journal 20090101
-
Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates.
PloS one 20090101
-
Towards a sane and rational approach to management of Influenza H1N1 2009.
Virology journal 20090101
-
Sales of oseltamivir in Norway prior to the emergence of oseltamivir resistant influenza A(H1N1) viruses in 2007-08.
Virology journal 20090101
-
Influenza.
BMJ clinical evidence 20090101
-
Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites.
Biology direct 20090101
-
Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.
Virology journal 20090101
-
Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses.
PloS one 20090101
-
Q&A: What do we know about influenza and what can we do about it?
Journal of biology 20090101
-
[Influenza A (H1N1): proposed guideline for hospital management of confirmed or suspected cases].
Igiene e sanita pubblica 20090101
-
Pandemic influenza: implications for occupational medicine.
Journal of occupational medicine and toxicology (London, England) 20090101
-
Detection of the antiviral drug oseltamivir in aquatic environments.
PloS one 20090101
-
Respiratory tract infection during Hajj.
Annals of thoracic medicine 20090101
-
Swine influenza A (H1N1) strikes a potential for global disaster.
Journal of emergencies, trauma, and shock 20090101
-
Production of N-acetyl-D-neuraminic acid using two sequential enzymes overexpressed as double-tagged fusion proteins.
BMC biotechnology 20090101
-
Dimensions of design space: a decision-theoretic approach to optimal research design.
Medical decision making : an international journal of the Society for Medical Decision Making 20090101
-
Age-prioritized use of antivirals during an influenza pandemic.
BMC infectious diseases 20090101
-
Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.
BMJ (Clinical research ed.) 20090101
-
Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.
Virology journal 20090101
-
A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells.
International journal of biological sciences 20090101
-
Q&A: What have we found out about the influenza A (H1N1) 2009 pandemic virus?
Journal of biology 20090101
-
Finding a new drug and vaccine for emerging swine flu: what is the concept?
Biologics : targets & therapy 20090101
-
Inhibition of RNA recruitment and replication of an RNA virus by acridine derivatives with known anti-prion activities.
PloS one 20090101
-
Myocarditis mimicking acute coronary syndrome following influenza B virus infection: a case report.
Cases journal 20090101
-
Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication.
PloS one 20090101
-
[New influenza A (H1N1): advised indication and prescription of antiviral drugs].
Nederlands tijdschrift voor geneeskunde 20090101
-
Coming soon to an ICU near you: severe pandemic influenza in ICU patients in Spain.
Critical care (London, England) 20090101
-
The novel influenza A (H1N1) virus pandemic: An update.
Annals of thoracic medicine 20090101
-
Antiviral activity of gliotoxin, gentian violet and brilliant green against Nipah and Hendra virus in vitro.
Virology journal 20090101
-
H1N1 pandemic: life span considerations.
AACN advanced critical care 20090101
-
Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
PloS one 20090101
-
Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.
PloS one 20090101
-
Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV).
Virology journal 20090101
-
H1N1 influenza A infection.
Hippokratia 20090101
-
Epidemic modeling with discrete-space scheduled walkers: extensions and research opportunities.
BMC public health 20090101
-
Characterization of the influenza A H5N1 viruses of the 2008-09 outbreaks in India reveals a third introduction and possible endemicity.
PloS one 20090101
-
Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.
PloS one 20090101
-
Novel influenza A (H1N1): what nurses need to know.
Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses 20090101
-
Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
Drugs 20090101
-
Post-exposure prophylaxis during pandemic outbreaks.
BMC medicine 20090101
-
Modeling gene sequences over time in 2009 H1N1 influenza A virus populations.
Virology journal 20090101
-
Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis.
BMJ (Clinical research ed.) 20090101
-
Combination strategies for pandemic influenza response - a systematic review of mathematical modeling studies.
BMC medicine 20090101
-
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidases.
PloS one 20090101
-
Antiviral strategies: the present and beyond.
Current molecular pharmacology 20090101
-
Influenza in outpatient ILI case-patients in national hospital-based surveillance, Bangladesh, 2007-2008.
PloS one 20090101
-
Influenza A (H1N1) in Rome, Italy in family: three case reports.
Cases journal 20090101
-
Are Belgian senior medical students ready to deliver basic medical care in case of a H5N1 pandemic?
Prehospital and disaster medicine 20090101
-
Clinical review: primary influenza viral pneumonia.
Critical care (London, England) 20090101
-
Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
Indian journal of physiology and pharmacology 20090101
-
Novel influenza H1N1 in pregnancy: a report of two cases.
Infectious diseases in obstetrics and gynecology 20090101
-
Phylogenetic analysis of surface proteins of novel H1N1 virus isolated from 2009 pandemic.
Bioinformation 20090101
-
Seasonal influenza: waiting for the next pandemic.
Journal of global infectious diseases 20090101
-
Mitigation approaches to combat the flu pandemic.
Journal of global infectious diseases 20090101
-
Pandemic (H1N1) 2009: epidemiological, clinical and prevention aspects.
The National medical journal of India 20090101
-
Swine flu.
Journal of infection and public health 20090101
-
Foreword: this issue of the Seton Hall Law Review presents contributions to Preparing for Pharmaceutical Response to Pandemic Influenza, a two-day Symposium held at Seton hall University School of Law in the fall of 2008.
Seton Hall law review 20090101
-
Swine- Origin Influenza A (H1N1) Pandemic Revisited.
The Libyan journal of medicine 20090101
-
Antiinfluenza medication kits need work, FDA advisers conclude.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081215
-
Antiviral drugs for influenza.
The Medical letter on drugs and therapeutics 20081201
-
Recommendations for the prevention and treatment of influenza using antiviral drugs based on cost-effectiveness.
Expert review of pharmacoeconomics & outcomes research 20081201
-
Evaluation of intravenous zanamivir against experimental influenza A (H5N1) virus infection in cynomolgus macaques.
Antiviral research 20081101
-
A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
Journal of virological methods 20081101
-
Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa.
Emerging infectious diseases 20081101
-
Meeting report: risk assessment of tamiflu use under pandemic conditions.
Environmental health perspectives 20081101
-
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Journal of medicinal chemistry 20081009
-
Insights into inflammation and influenza.
The New England journal of medicine 20081009
-
Limited inhibitory effects of oseltamivir and zanamivir on human sialidases.
Antimicrobial agents and chemotherapy 20081001
-
Antivirals and influenza: frequency of resistance.
The Pediatric infectious disease journal 20081001
-
In vitro evaluation of neuraminidase inhibitors using the neuraminidase-dependent release assay of hemagglutinin-pseudotyped viruses.
Antiviral research 20080901
-
Preparation of active proteins, vaccines and pharmaceuticals as fine powders using supercritical or near-critical fluids.
Pharmaceutical research 20080901
-
Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Journal of chemical information and modeling 20080901
-
Structure of the catalytic domain of Streptococcus pneumoniae sialidase NanA.
Acta crystallographica. Section F, Structural biology and crystallization communications 20080901
-
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 20080808
-
Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080801
-
Editorial commentary: viral susceptibility and the choice of influenza antivirals.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080801
-
Modifying clinical practices to manage influenza in children effectively.
The Pediatric infectious disease journal 20080801
-
Oseltamivir prescribing in pharmacy-benefits database, United States, 2004-2005.
Emerging infectious diseases 20080801
-
Zanamivir: new indication. Influenza: in children as in adults, symptom relief or vaccination.
Prescrire international 20080801
-
Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase.
Journal of medicinal chemistry 20080710
-
Enzymatic properties of the neuraminidase of seasonal H1N1 influenza viruses provide insights for the emergence of natural resistance to oseltamivir.
PLoS pathogens 20080701
-
Statement on influenza vaccination for the 2008-2009 season. An Advisory Committee Statement (ACS).
Canada communicable disease report = Releve des maladies transmissibles au Canada 20080701
-
[Neuraminidase inhibitors in prophylaxis and treatment of influenza].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20080701
-
Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants.
Nature 20080626
-
Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
Proteins 20080601
-
PA subunit of RNA polymerase as a promising target for anti-influenza virus agents.
Antiviral research 20080601
-
Major issues and challenges of influenza pandemic preparedness in developing countries.
Emerging infectious diseases 20080601
-
[Bird flu: what the intensivist must know].
Medicina intensiva 20080501
-
Human metapneumovirus infection in immunocompromised child.
Emerging infectious diseases 20080501
-
Molecular strategies to inhibit the replication of RNA viruses.
Antiviral research 20080401
-
Current and future antiviral therapy of severe seasonal and avian influenza.
Antiviral research 20080401
-
Oseltamivir, an anti-influenza virus drug, produces hypothermia in mice.
Biological & pharmaceutical bulletin 20080401
-
Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
Pediatrics 20080401
-
Determination of oseltamivir quality by colorimetric and liquid chromatographic methods.
Emerging infectious diseases 20080401
-
Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.
PLoS pathogens 20080401
-
Lessons learned from the 2007-2008 cold and flu season: what worked and what was worthless.
Urologic nursing 20080401
-
Hydrophobic polycationic coatings inactivate wild-type and zanamivir- and/or oseltamivir-resistant human and avian influenza viruses.
Biotechnology letters 20080301
-
Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
Bioorganic & medicinal chemistry letters 20080301
-
Influenza.
Canadian family physician Medecin de famille canadien 20080301
-
[Analysis of decrease in sensitivity in influenza A (H5N1) avian and human strains to neuraminidase inhibitors].
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20080301
-
Synthetic efforts for stereo structure determination of cytotoxic marine natural product pericosines as metabolites of Periconia sp. from sea hare.
International journal of molecular sciences 20080301
-
[Influenza].
La Revue du praticien 20080227
-
Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble.
Chemical biology & drug design 20080201
-
Cost-effectiveness of antiviral stockpiling and near-patient testing for potential influenza pandemic.
Emerging infectious diseases 20080201
-
[Influenza in children: what should be considered in prevention and treatment?].
Kinderkrankenschwester : Organ der Sektion Kinderkrankenpflege 20080201
-
Amantadine and rimantadine for influenza A in children and the elderly.
The Cochrane database of systematic reviews 20080123
-
A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.
The Journal of infection 20080101
-
Medical management of influenza infection.
Annual review of medicine 20080101
-
Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20080101
-
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20080101
-
Whatever happened to bird flu?
Reviews in medical virology 20080101
-
Coutilization of glucose and glycerol enhances the production of aromatic compounds in an Escherichia coli strain lacking the phosphoenolpyruvate: carbohydrate phosphotransferase system.
Microbial cell factories 20080101
-
Pandemic influenza and pregnant women.
Emerging infectious diseases 20080101
-
Proposed lead molecules against Hemagglutinin of avian influenza virus (H5N1).
Bioinformation 20080101
-
Cost-effectiveness and value of information analyses of neuraminidase inhibitors for the treatment of influenza.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20080101
-
Do pediatricians manage influenza differently than internists?
BMC pediatrics 20080101
-
Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.
PloS one 20080101
-
The metabolism and transplacental transfer of oseltamivir in the ex vivo human model.
Infectious diseases in obstetrics and gynecology 20080101
-
Bench-to-bedside review: rare and common viral infections in the intensive care unit--linking pathophysiology to clinical presentation.
Critical care (London, England) 20080101
-
Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay.
Virology journal 20080101
-
Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam.
PloS one 20080101
-
Oseltamivir is adequately absorbed following nasogastric administration to adult patients with severe H5N1 influenza.
PloS one 20080101
-
Avian Influenza: a global threat needing a global solution.
Asia Pacific family medicine 20080101
-
Current research on drugs and vaccines for fighting bird flu.
Transactions of the Royal Society of Tropical Medicine and Hygiene 20071201
-
Neuraminidase inhibitor drug susceptibility differs between influenza N1 and N2 neuraminidase following mutagenesis of two conserved residues.
Antiviral research 20071201
-
The war against influenza: discovery and development of sialidase inhibitors.
Nature reviews. Drug discovery 20071201
-
Neuraminidase inhibitor resistance in influenza: assessing the danger of its generation and spread.
PLoS computational biology 20071201
-
Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic.
Infectious disorders drug targets 20071201
-
[Influenza in children].
La Revue du praticien 20071115
-
[Countermeasures for newly-emerging influenza].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20071110
-
Characterization of human H1N1 influenza virus variants selected in vitro with zanamivir in the presence of sialic acid-containing molecules.
Virus research 20071101
-
[Antiviral treatment of influenza in humans].
Therapeutische Umschau. Revue therapeutique 20071101
-
Neuraminidase inhibitor resistance in influenza viruses.
Journal of medical virology 20071001
-
The role of oseltamivir in the treatment and prevention of influenza in children.
Expert opinion on drug metabolism & toxicology 20071001
-
Synthesis of C-4 and C-7 triazole analogs of zanamivir as multivalent sialic acid containing scaffolds.
Carbohydrate research 20070903
-
Neuraminidase inhibitor susceptibility of porcine H3N2 influenza A viruses isolated in Germany between 1982 and 1999.
Antiviral research 20070901
-
Synthesis and anti-influenza activities of carboxyl alkoxyalkyl esters of 4-guanidino-Neu5Ac2en (zanamivir).
Bioorganic & medicinal chemistry letters 20070901
-
Influenza: the virus and prophylaxis with inactivated influenza vaccine in 'at risk' groups, including COPD patients.
International journal of chronic obstructive pulmonary disease 20070901
-
Reduced sensitivity of influenza A (H5N1) to oseltamivir.
Emerging infectious diseases 20070901
-
Avian influenza: should China be alarmed?
Yonsei medical journal 20070831
-
Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
Clinical therapeutics 20070801
-
John F. Enders lecture 2006: antivirals for influenza.
The Journal of infectious diseases 20070715
-
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 20070713
-
The bird flu: a new emerging pandemic threat and its pharmacological intervention.
International journal of health sciences 20070701
-
Zanamivir treatment is equally effective for both influenza A and influenza B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20070615
-
Determination of zanamivir in rat and monkey plasma by positive ion hydrophilic interaction chromatography (HILIC)/tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070601
-
Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention.
Trends in pharmacological sciences 20070601
-
The Diskus: a review of its position among dry powder inhaler devices.
International journal of clinical practice 20070601
-
Zanamivir for the prevention of influenza in adults and children age 5 years and older.
Therapeutics and clinical risk management 20070601
-
Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir.
Antiviral research 20070501
-
Transparent development of the WHO rapid advice guidelines.
PLoS medicine 20070501
-
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza.
PLoS medicine 20070501
-
Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.
Releve epidemiologique hebdomadaire 20070427
-
[Threat from newly emerging influenza].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070410
-
Antiviral therapy and prophylaxis for influenza in children.
Pediatrics 20070401
-
Influenza: evolving strategies in treatment and prevention.
Seminars in respiratory and critical care medicine 20070401
-
Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006/2007 season.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20070401
-
Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
Biochemical and biophysical research communications 20070316
-
Synthesis and evaluation of 4-O-alkylated 2-deoxy-2,3-didehydro-N-acetylneuraminic acid derivatives as inhibitors of human parainfluenza virus type-3 sialidase activity.
Bioorganic & medicinal chemistry letters 20070315
-
Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes.
Antiviral research 20070301
-
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice.
Antimicrobial agents and chemotherapy 20070301
-
[Zanamivir for prevention of influenza and in children].
Medizinische Monatsschrift fur Pharmazeuten 20070301
-
Drug-induced linear immunoglobulin A bullous dermatosis mimicking Stevens-Johnson syndrome: a case report.
Cutis 20070301
-
Occasional review: influenza in COPD: pathogenesis, prevention, and treatment.
International journal of chronic obstructive pulmonary disease 20070301
-
Prevention and control of influenza in persons with chronic obstructive pulmonary disease.
International journal of chronic obstructive pulmonary disease 20070301
-
Influenza infection and COPD.
International journal of chronic obstructive pulmonary disease 20070301
-
[Antiviral agents for influenza].
Nihon rinsho. Japanese journal of clinical medicine 20070227
-
Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005.
Antiviral research 20070201
-
Oseltamivir: new indication. Prevention of influenza in at-risk children: vaccination is best.
Prescrire international 20070201
-
Neuraminidase inhibitors for preventing and treating influenza in children.
The Cochrane database of systematic reviews 20070124
-
Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials.
American journal of epidemiology 20070115
-
How influenza's neuraminidase promotes virulence and creates localized lung mucosa immunodeficiency.
Cellular & molecular biology letters 20070101
-
[Neuraminidase inhibitors and risk of H5N1 influenza].
Annales pharmaceutiques francaises 20070101
-
Potential risks associated with the proposed widespread use of Tamiflu.
Environmental health perspectives 20070101
-
Questioning aerosol transmission of influenza.
Emerging infectious diseases 20070101
-
Graphical representation and numerical characterization of H5N1 avian flu neuraminidase gene sequence.
Journal of chemical information and modeling 20070101
-
Clinical review: update of avian influenza A infections in humans.
Critical care (London, England) 20070101
-
Low pH gel intranasal sprays inactivate influenza viruses in vitro and protect ferrets against influenza infection.
Respiratory research 20070101
-
Avian influenza: an osteopathic component to treatment.
Osteopathic medicine and primary care 20070101
-
Failure of zanamivir therapy for pneumonia in a bone-marrow transplant recipient infected by a zanamivir-sensitive influenza A (H1N1) virus.
Antiviral therapy 20070101
-
General practitioners' management of influenza with or without neuraminidase inhibitors.
The European journal of general practice 20070101
-
PocketPicker: analysis of ligand binding-sites with shape descriptors.
Chemistry Central journal 20070101
-
Recent anti-influenza strategies in multivalent sialyloligosaccharides and sialylmimetics approaches.
Current medicinal chemistry 20070101
-
Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus.
PloS one 20070101
-
Neuraminidase inhibitors and their role in avian and pandemic influenza.
Antiviral therapy 20070101
-
M2 protein-a proton channel of influenza A virus.
Current pharmaceutical design 20070101
-
A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination.
PloS one 20070101
-
Strategies of development of antiviral agents directed against influenza virus replication.
Current pharmaceutical design 20070101
-
Antivirals for the treatment and prevention of epidemic and pandemic influenza.
Influenza and other respiratory viruses 20070101
-
Characterization of multidrug-resistant influenza A/H3N2 viruses shed during 1 year by an immunocompromised child.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20061215
-
Pharmacokinetics and dosage adjustment of oseltamivir and zanamivir in patients with renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20061201
-
Antiviral agents active against influenza A viruses.
Nature reviews. Drug discovery 20061201
-
Antivirals in the management of an influenza pandemic.
The Medical journal of Australia 20061120
-
A nanoscale study of particle friction in a pharmaceutical system.
International journal of pharmaceutics 20061115
-
Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005.
Vaccine 20061110
-
Scientific lessons from the first influenza pandemic of the 20th century.
Vaccine 20061110
-
Which agents should we use to treat and prevent influenza in 2006-2007?
Cleveland Clinic journal of medicine 20061101
-
Antiviral management of seasonal and pandemic influenza.
The Journal of infectious diseases 20061101
-
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
The Journal of infectious diseases 20061101
-
Antiviral drugs prophylaxis and treatment of influenza.
The Medical letter on drugs and therapeutics 20061023
-
Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities.
Bioorganic & medicinal chemistry letters 20061001
-
Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro.
The Journal of antimicrobial chemotherapy 20061001
-
[Treatment of influenza virus infection with anti-virals].
Nihon rinsho. Japanese journal of clinical medicine 20061001
-
The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.
Nature 20060907
-
Symptomatic predictors of influenza virus positivity in children during the influenza season.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20060901
-
Safety of neuraminidase inhibitors for influenza.
Expert opinion on drug safety 20060901
-
Possible case scenarios and logistic issues in H5N1 pandemic.
Respirology (Carlton, Vic.) 20060901
-
State plans for containment of pandemic influenza.
Emerging infectious diseases 20060901
-
[Various sides of influenza. Part II--epidemiology, influenza surveillance and prophylaxis].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20060901
-
[Avian influenza pandemic prevention - current research].
Revue medicale suisse 20060823
-
Neuraminidase inhibitors for preventing and treating influenza in healthy adults.
The Cochrane database of systematic reviews 20060719
-
Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.
Antimicrobial agents and chemotherapy 20060701
-
Insights from modeling the 3D structure of H5N1 influenza virus neuraminidase and its binding interactions with ligands.
Biochemical and biophysical research communications 20060609
-
Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors.
Medical microbiology and immunology 20060601
-
Non-voluntary licensing of antivirals under patent: options the Australian Government should consider in light of a potential bird flu pandemic.
Journal of law and medicine 20060501
-
[Role of influenza virus sialidase].
Seikagaku. The Journal of Japanese Biochemical Society 20060501
-
Human cell lines used in a micro neutralization test for measuring influenza-neutralizing antibodies.
Scandinavian journal of immunology 20060401
-
In vitro efficacies of oseltamivir carboxylate and zanamivir against equine influenza A viruses.
The Journal of veterinary medical science 20060401
-
Roles of neuraminidase in the initial stage of influenza virus infection.
Microbes and infection 20060401
-
Human influenza surveillance: the demand to expand.
Emerging infectious diseases 20060401
-
Oseltamivir resistance in influenza A (H5N1) infection.
The New England journal of medicine 20060330
-
Increased antiviral medication sales before the 2005-06 influenza season--New York City.
MMWR. Morbidity and mortality weekly report 20060317
-
[What do your patients want to know now? The most frequent questions about avian influenza].
MMW Fortschritte der Medizin 20060302
-
Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.
Pharmacotherapy 20060301
-
[Neuraminidase inhibitors are effective in influenza---if administered quickly after the debut or as prophylaxis to infected persons].
Lakartidningen 20060301
-
A QSAR study on influenza neuraminidase inhibitors.
Bioorganic & medicinal chemistry 20060215
-
Influenza diagnosis and treatment in veterans with spinal cord injury.
Archives of physical medicine and rehabilitation 20060201
-
Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire international 20060201
-
[Epidemiology, clinical picture, prevention and treatment of Avian influenza].
Georgian medical news 20060201
-
Review says oseltamivir and zanamivir should be kept for epidemics of flu.
BMJ (Clinical research ed.) 20060128
-
Antivirals for influenza in healthy adults: systematic review.
Lancet (London, England) 20060128
-
High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.
MMWR. Morbidity and mortality weekly report 20060120
-
Anti-influenza virus activity of peramivir in mice with single intramuscular injection.
Antiviral research 20060101
-
Vaccines and antiviral drugs in pandemic preparedness.
Emerging infectious diseases 20060101
-
Pandemic influenza threat and preparedness.
Emerging infectious diseases 20060101
-
Combating influenza with antiviral therapy in the pediatric population.
Pharmacotherapy 20060101
-
[Nosocomial outbreak of influenza in high-risk hematological patients. Efficacy of control measures and the use of zanamivir].
Enfermedades infecciosas y microbiologia clinica 20060101
-
In vitro inhibition of human influenza A virus replication by chloroquine.
Virology journal 20060101
-
Influenza virus inhibitors available for the chemotherapy and/or chemoprophylaxis of influenza virus infections.
Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie 20060101
-
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice.
Respiratory research 20060101
-
A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics.
BMC medicine 20060101
-
[Antiviral etiotropic chemicals: efficacy against influenza A viruses A subtype H5N1].
Voprosy virusologii 20060101
-
A comparative study on the cost of new antibiotics and drugs of other therapeutic categories.
PloS one 20060101
-
Neuraminidase inhibitors reduce nitric oxide production in influenza virus-infected and gamma interferon-activated RAW 264.7 macrophages.
Pharmacological reports : PR 20060101
-
Another option for flu prevention.
FDA consumer 20060101
-
[Significance of virological diagnostics for the effective treatment of hospitalized patients infected with influenza virus].
Pneumonologia i alergologia polska 20060101
-
Impact of neuraminidase mutations conferring influenza resistance to neuraminidase inhibitors in the N1 and N2 genetic backgrounds.
Antiviral therapy 20060101
-
Molecular drug targets and structure based drug design: A holistic approach.
Bioinformation 20060101
-
Oseltamivir resistance--disabling our influenza defenses.
The New England journal of medicine 20051222
-
Consideration of use of neuraminidase inhibitors such as oseltamivir and zanamivir in IgA nephropathy.
Kidney international 20051201
-
Star role for bacteria in controlling flu pandemic?
Nature reviews. Drug discovery 20051201
-
[Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].
Lakartidningen 20051201
-
Neuraminidase inhibitors as antiviral agents.
Current drug targets. Infectious disorders 20051201
-
[Influenza prevention in your practice (interview by Waldtraud Paukstadt)].
MMW Fortschritte der Medizin 20051117
-
Avian flu: isolation of drug-resistant H5N1 virus.
Nature 20051020
-
Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.
Antiviral research 20051001
-
One-bead-one-inhibitor-one-substrate screening of neuraminidase activity.
Chembiochem : a European journal of chemical biology 20051001
-
Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors.
The Pediatric infectious disease journal 20051001
-
Use of antiviral agents and other measures in an influenza pandemic.
The Netherlands journal of medicine 20051001
-
Evolution of H5N1 avian influenza viruses in Asia.
Emerging infectious diseases 20051001
-
Neuraminidase inhibitors for influenza.
The New England journal of medicine 20050929
-
Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom.
The European journal of health economics : HEPAC : health economics in prevention and care 20050901
-
Threat of pandemic brings flu drug back to life.
Nature medicine 20050901
-
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice.
The Journal of infectious diseases 20050815
-
Cost-benefit of stockpiling drugs for influenza pandemic.
Emerging infectious diseases 20050801
-
Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo.
Bioorganic & medicinal chemistry 20050602
-
Prediction of genotoxicity of chemical compounds by statistical learning methods.
Chemical research in toxicology 20050601
-
[Anti-virals for influenza virus infection].
Uirusu 20050601
-
Avian flu special: what's in the medicine cabinet?
Nature 20050526
-
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza.
Journal of medicinal chemistry 20050421
-
Zanamivir: an influenza virus neuraminidase inhibitor.
Expert review of anti-infective therapy 20050401
-
Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations.
The Journal of antimicrobial chemotherapy 20050201
-
A side effect of neuraminidase inhibitor in a patient with liver cirrhosis.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20050201
-
[Antivirals for influenza].
Bulletin de l'Academie nationale de medecine 20050201
-
Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance.
Treatments in respiratory medicine 20050101
-
Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other 'virus receptor' diseases.
Virology journal 20050101
-
Antiviral agents for influenza: a comparison of cost-effectiveness data.
PharmacoEconomics 20050101
-
H5N1.
Genome biology 20050101
-
Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population.
Journal of the American Medical Directors Association 20050101
-
Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population.
Journal of the American Medical Directors Association 20050101
-
Neuraminidase inhibitor susceptibility network position statement: antiviral resistance in influenza A/H5N1 viruses.
Antiviral therapy 20050101
-
Pharmacoeconomics of antiviral therapy for influenza in a Japanese hospital setting.
Clinical drug investigation 20050101
-
Therapy of hearing disorders - conservative procedures.
GMS current topics in otorhinolaryngology, head and neck surgery 20050101
-
[Zanamivir, oseltamivir].
Nihon rinsho. Japanese journal of clinical medicine 20041201
-
Influenza.
Clinical evidence 20041201
-
[Super pathogenic avian influenza].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20041110
-
Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20041109
-
Vaccines for women age 50 and older.
Emerging infectious diseases 20041101
-
Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20041001
-
Avian influenza should be ruffling our feathers.
The Lancet. Infectious diseases 20041001
-
What is the best antiviral agent for influenza infection?
American family physician 20041001
-
Influenza among U.K. pilgrims to hajj, 2003.
Emerging infectious diseases 20041001
-
In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.
Antiviral research 20040901
-
A reverse genetics study of resistance to neuraminidase inhibitors in an influenza A/H1N1 virus.
Antiviral therapy 20040801
-
Medical economics in the field of influenza--past, present and future.
Virus research 20040701
-
A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.
Virus research 20040701
-
Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.
Virus research 20040701
-
Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.
Virus research 20040701
-
Synthesis of 4-azido-4-deoxy-Neu5,7,8,9Ac42en1Me. A key intermediate for the synthesis of GG167 from D-glucono-delta-lactone.
Organic letters 20040624
-
Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy.
The Medical journal of Australia 20040621
-
Neuraminidase inhibitors for treatment of influenza.
American family physician 20040615
-
Biotech business Down Under.
Nature 20040603
-
Antiviral drugs in current clinical use.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040601
-
Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host.
The Journal of antimicrobial chemotherapy 20040501
-
Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
Current opinion in pulmonary medicine 20040501
-
Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
Virology 20040501
-
[Treatment for viral respiratory infections: Principles of action, strategies, and future prospects].
Der Internist 20040401
-
Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir.
Antiviral research 20040401
-
Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs.
Emerging infectious diseases 20040401
-
Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 20040326
-
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidase.
Bioorganic & medicinal chemistry letters 20040322
-
[Strategies in the diagnosis and treatment of patients with avian influenza].
Zhonghua yi xue za zhi 20040302
-
Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040301
-
A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community.
The Journal of antimicrobial chemotherapy 20040201
-
An evaluation of the impact of NICE guidance on GP prescribing.
The British journal of general practice : the journal of the Royal College of General Practitioners 20040201
-
Controlling influenza by inhibiting the virus's neuraminidase.
Current drug targets 20040201
-
[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].
Nederlands tijdschrift voor geneeskunde 20040110
-
Phenotypic drug susceptibility assay for influenza virus neuraminidase inhibitors.
Clinical and diagnostic laboratory immunology 20040101
-
Influenza infection of the embryonated hen's egg/an alternative model for in vivo evaluation of antiviral compounds.
Arzneimittel-Forschung 20040101
-
Antiviral therapy for influenza : a clinical and economic comparative review.
Drugs 20040101
-
Investigation of neuraminidase-substrate recognition using molecular dynamics and free energy calculations.
Journal of medicinal chemistry 20031218
-
[English meta-analysis on zanamivir and oseltamivir. Knowledge of effects of influenza agents still not sufficient].
Lakartidningen 20031211
-
Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
Chemical & pharmaceutical bulletin 20031201
-
Influenza.
Clinical evidence 20031201
-
Assessment of development of resistance to antivirals in the ferret model of influenza virus infection.
The Journal of infectious diseases 20031101
-
[Clinical characteristic of the elderly in influenza infection].
Nihon rinsho. Japanese journal of clinical medicine 20031101
-
[Influenza virus infection in children].
Nihon rinsho. Japanese journal of clinical medicine 20031101
-
[Criteria for the use of anti-influenza agents].
Nihon rinsho. Japanese journal of clinical medicine 20031101
-
[Neuraminidase inhibitor, anti-influenzal agent--mechanism of action, and how to use clinically].
Nihon rinsho. Japanese journal of clinical medicine 20031101
-
Combination anti-inflammatory and antiviral therapy of influenza in a cotton rat model.
Pediatric pulmonology 20031001
-
Management of influenza symptoms in healthy adults.
Journal of general internal medicine 20031001
-
Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
The Journal of family practice 20031001
-
Nosocomial influenza in children.
The Journal of hospital infection 20031001
-
Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy.
Annals of internal medicine 20030902
-
Summaries for patients. Cost-effective management of flu in adults older than 65 years of age.
Annals of internal medicine 20030902
-
Emergence of amantadine-resistant influenza A viruses: epidemiological study.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20030901
-
Clinical features of influenza a virus infection in older hospitalized persons.
Journal of the American Geriatrics Society 20030801
-
Influenza therapy.
Southern medical journal 20030801
-
Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents.
Bioorganic & medicinal chemistry 20030703
-
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.
BMJ (Clinical research ed.) 20030607
-
We need to determine who benefits most from flu treatments.
BMJ (Clinical research ed.) 20030607
-
Oseltamivir: new preparation. An antiviral agent with little impact on influenza.
Prescrire international 20030601
-
New application method of zanamivir with a straw.
Pediatrics international : official journal of the Japan Pediatric Society 20030601
-
A point mutation in influenza B neuraminidase confers resistance to peramivir and loss of slow binding.
Antiviral research 20030601
-
Review of the use of neuraminidase inhibitors for prophylaxis of influenza.
Communicable disease and public health 20030601
-
Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.
Antiviral therapy 20030601
-
[Influenza in global aspect].
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20030601
-
The role of antivirals in the control of influenza.
Vaccine 20030501
-
Pandemic influenza and healthcare demand in the Netherlands: scenario analysis.
Emerging infectious diseases 20030501
-
Zanamivir in the treatment of influenza.
Expert opinion on pharmacotherapy 20030501
-
Compared protective effect of nasal immunoprophylaxis using a new human monoclonal IgM antibody, human polyclonal antibodies, F(ab')2, amantadine, and zanamivir for prophylaxis of influenza A virus pneumonia in mice.
Military medicine 20030301
-
Semi-quantitative detection of viral RNA in influenza A virus-infected mice for evaluation of antiviral compounds.
Antiviral research 20030301
-
Synthesis and anti-influenza evaluation of orally active bicyclic ether derivatives related to zanamivir.
Bioorganic & medicinal chemistry letters 20030224
-
Antiviral drugs in the immunocompetent host: part II. Treatment of influenza and respiratory syncytial virus infections.
American family physician 20030215
-
Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary care.
Journal of the Royal Society of Medicine 20030201
-
Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza.
The Pediatric infectious disease journal 20030201
-
[Influenza].
Nihon rinsho. Japanese journal of clinical medicine 20030201
-
[Antiviral agents for influenza].
Nihon rinsho. Japanese journal of clinical medicine 20030201
-
[Treatment of influenza in children].
Zhonghua er ke za zhi = Chinese journal of pediatrics 20030201
-
Influenza neuraminidase inhibitors: structure-based design of a novel inhibitor series.
Biochemistry 20030128
-
[Oral neuraminidase inhibitor and an early warning system. New weapons against influenza].
MMW Fortschritte der Medizin 20030123
-
The treatment of influenza with antiviral drugs.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030107
-
Neuraminidase inhibitors in pediatric patients: potential place in influenza therapy.
Paediatric drugs 20030101
-
Bedside rapid flu test and zanamivir prescription in healthy working adults: a cost-benefit analysis.
PharmacoEconomics 20030101
-
Influenza vaccination and antiviral therapy: is there a role for concurrent administration in the institutionalised elderly?
Drugs & aging 20030101
-
Treatment and prevention of influenza: Swedish recommendations.
Scandinavian journal of infectious diseases 20030101
-
Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza.
Scandinavian journal of infectious diseases 20030101
-
Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20030101
-
[Influenza].
Revista da Sociedade Brasileira de Medicina Tropical 20030101
-
Neuraminidase inhibitors for preventing and treating influenza in children.
The Cochrane database of systematic reviews 20030101
-
Assaying susceptibility of avian and other influenza A viruses to zanamivir: comparison of fluorescent and chemiluminescent neuraminidase assays.
Avian diseases 20030101
-
Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.
Health technology assessment (Winchester, England) 20030101
-
Progress toward generating a ferret model of cystic fibrosis by somatic cell nuclear transfer.
Reproductive biology and endocrinology : RB&E 20030101
-
Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.
Communicable diseases intelligence quarterly report 20030101
-
Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
The Journal of infectious diseases 20021201
-
Problems of case and disease management in outpatient treatment of influenza.
Medical microbiology and immunology 20021201
-
Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
Medical microbiology and immunology 20021201
-
Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
Medical microbiology and immunology 20021201
-
Drug under test: influenza--Relenza in daily practice. Experience during the influenza season 1999/2000.
Medical microbiology and immunology 20021201
-
[Patient assessment for zanamivir therapy (second report) -- a survey of patients with influenza who were prescribed zanamivir during the 2001/2002 season in Japan].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20021201
-
Oseltamivir for influenza.
Drug and therapeutics bulletin 20021201
-
[New diagnostic possibilities and medications. Fit for influenza?].
MMW Fortschritte der Medizin 20021128
-
Risk for respiratory events in a cohort of patients receiving inhaled zanamivir: a retrospective study.
Clinical therapeutics 20021101
-
The effect of zanamivir treatment on influenza complications: a retrospective cohort study.
Clinical therapeutics 20021101
-
Affinity scale between a carrier and a drug in DPI studied by atomic force microscopy.
International journal of pharmaceutics 20021024
-
Characterization of 2 influenza A(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhibitors due to mutations in the hemagglutinin gene.
The Journal of infectious diseases 20021015
-
[Neuraminidase inhibitor permitted. The first pill against influenza].
MMW Fortschritte der Medizin 20021010
-
Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.
Journal of virological methods 20021001
-
Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing care population.
Infection control and hospital epidemiology 20021001
-
Current strategies for management of influenza in the elderly population.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20020915
-
Influenza prevention 2002-2003.
The Medical letter on drugs and therapeutics 20020902
-
Cost-effectiveness of newer treatment strategies for influenza.
The American journal of medicine 20020901
-
Economic analysis of influenza vaccination and antiviral treatment for healthy working adults.
Annals of internal medicine 20020820
-
Summaries for patients. Influenza vaccination or antiviral treatment for healthy working adults: an economic analysis.
Annals of internal medicine 20020820
-
Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.
Bioorganic & medicinal chemistry letters 20020805
-
Synthesis and anti-influenza virus activity of 7-O-alkylated derivatives related to zanamivir.
Bioorganic & medicinal chemistry letters 20020805
-
Synthesis and anti-influenza evaluation of polyvalent sialidase inhibitors bearing 4-guanidino-Neu5Ac2en derivatives.
Bioorganic & medicinal chemistry letters 20020805
-
Development of a novel influenza A antiviral assay.
Journal of virological methods 20020801
-
The management of influenza in people of working age.
Occupational medicine (Oxford, England) 20020801
-
Management of viral infections in immunocompromised cancer patients.
Swiss medical weekly 20020713
-
Analysis of the desialidation process of the haemagglutinin protein of influenza B virus: the host-dependent desialidation step.
The Journal of general virology 20020701
-
In vitro selection and characterization of influenza A (A/N9) virus variants resistant to a novel neuraminidase inhibitor, A-315675.
Journal of virology 20020601
-
Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza.
Expert opinion on investigational drugs 20020601
-
Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors.
Antiviral research 20020601
-
Gateways to Clinical Trials. June 2002.
Methods and findings in experimental and clinical pharmacology 20020601
-
[A revolutionary change in the diagnosis and treatment of influenza].
Uirusu 20020601
-
Influenza.
Clinical evidence 20020601
-
Structural studies of the resistance of influenza virus neuramindase to inhibitors.
Journal of medicinal chemistry 20020523
-
Role of phosphatidylserine exposure and sugar chain desialylation at the surface of influenza virus-infected cells in efficient phagocytosis by macrophages.
The Journal of biological chemistry 20020517
-
Neuraminidase inhibitors as antivirals.
Vaccine 20020515
-
Evidence-based emergency medicine/systematic review abstract. Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness.
Annals of emergency medicine 20020501
-
Exploitation of the Herpes simplex virus translocating protein VP22 to carry influenza virus proteins into cells for studies of apoptosis: direct confirmation that neuraminidase induces apoptosis and indications that other proteins may have a role.
Archives of virology 20020501
-
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 20020412
-
In vitro characterization of A-315675, a highly potent inhibitor of A and B strain influenza virus neuraminidases and influenza virus replication.
Antimicrobial agents and chemotherapy 20020401
-
Challenges and options in the management of viral infections after stem cell transplantation.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20020401
-
Antiviral therapy of influenza.
Seminars in pediatric infectious diseases 20020401
-
Highlights in the development of new antiviral agents.
Mini reviews in medicinal chemistry 20020401
-
Syncytium formation and HIV-1 replication are both accentuated by purified influenza and virus-associated neuraminidase.
The Journal of biological chemistry 20020322
-
[Pneumonia diagnosis in the practice on the test-bench: how much diagnosis is necessary?].
Deutsche medizinische Wochenschrift (1946) 20020315
-
Accumulation of defective neuraminidase (NA) genes by influenza A viruses in the presence of NA inhibitors as a marker of reduced dependence on NA.
The Journal of infectious diseases 20020301
-
Influenza in the acute hospital setting.
The Lancet. Infectious diseases 20020301
-
Neuraminidase inhibitors for the treatment and prevention of influenza.
Expert opinion on pharmacotherapy 20020201
-
Dry powder inhaler: influence of humidity on topology and adhesion studied by AFM.
International journal of pharmaceutics 20020131
-
Detection of influenza virus resistance to neuraminidase inhibitors by an enzyme inhibition assay.
Antiviral research 20020101
-
Zanamivir: an update of its use in influenza.
Drugs 20020101
-
Influenza in the nursing home.
American family physician 20020101
-
Patient perspective on zanamivir in the treatment of influenza.
International journal of clinical practice 20020101
-
The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
Bone marrow transplantation 20020101
-
Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
Health technology assessment (Winchester, England) 20020101
-
Antiviral therapy for influenza virus infections.
Seminars in pediatric infectious diseases 20020101
-
Zanamivir is an effective treatment for influenza in children undergoing therapy for acute lymphoblastic leukemia.
Scandinavian journal of infectious diseases 20020101
-
Antivirals for influenza: what is their role in the older patient?
Drugs & aging 20020101
-
Neuraminidase inhibitors in patients with underlying airways disease.
American journal of respiratory medicine : drugs, devices, and other interventions 20020101
-
Spotlight on zanamivir in influenza.
American journal of respiratory medicine : drugs, devices, and other interventions 20020101
-
Creating an integrated public sector? Labour's plans for the modernisation of the English health care system.
International journal of integrated care 20020101
-
Perspectives on antiviral use during pandemic influenza.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20011229
-
Zanamivir: from drug design to the clinic.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20011229
-
Treatment of influenza with neuraminidase inhibitors: virological implications.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20011229
-
Clinical effectiveness and cost effectiveness of zanamivir (Relenza): translating the evidence into clinical practice, a National Institute for Clinical Excellence view.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20011229
-
Zanamivir: an alternative translation.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20011229
-
Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity.
Journal of medicinal chemistry 20011206
-
Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201.
Antiviral research 20011201
-
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
Antimicrobial agents and chemotherapy 20011201
-
Management of influenza in patients with asthma or chronic obstructive pulmonary disease.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20011201
-
Zanamivir: a second look. Still no tangible impact on influenza.
Prescrire international 20011201
-
Are we ready for the next flu pandemic?
The Lancet. Infectious diseases 20011201
-
Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture.
Virus research 20011105
-
Vaccines for pneumonia and new antiviral therapies.
The Medical clinics of North America 20011101
-
Rapid pharmacotherapeutic intervention for an influenza A outbreak in the Canadian Arctic: lessons from the Sanikiluaq experience.
International journal of circumpolar health 20011101
-
Synthesis of influenza neuraminidase inhibitors.
Current opinion in drug discovery & development 20011101
-
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
Antimicrobial agents and chemotherapy 20011001
-
ACIP releases guidelines on the prevention and control of influenza. Advisory Committee on Immunization Practices.
American family physician 20011001
-
Therapeutic options for the management of influenza.
Current opinion in pharmacology 20011001
-
Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza.
Archives of internal medicine 20010924
-
The effect of zanamivir treatment on the early immune response to influenza vaccination.
Vaccine 20010914
-
Virology. The origin and control of pandemic influenza.
Science (New York, N.Y.) 20010907
-
[Patient assessment for zanamivir therapy--a survey of patients with influenza who were prescribed zanamivir during the 2000/2001 season in Japan].
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20010901
-
Unprepared for an influenza pandemic.
Lancet (London, England) 20010825
-
Antiviral drugs: current state of the art.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20010801
-
Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections.
The Medical journal of Australia 20010716
-
Elderly people's technique in using dry powder inhalers. Zanamivir and unreason seem to go together.
BMJ (Clinical research ed.) 20010707
-
Adverse cutaneous reactions to influenza vaccinations and chemotherapy.
International journal of dermatology 20010701
-
Advances in pharmacology. New treatments for influenza: neuraminidase inhibitors.
Medicine and health, Rhode Island 20010601
-
Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores.
Journal of medicinal chemistry 20010412
-
Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
Antimicrobial agents and chemotherapy 20010401
-
Managing influenza: amantadine, rimantadine and beyond.
International journal of clinical practice 20010401
-
Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid-6-propylamides.
Bioorganic & medicinal chemistry letters 20010312
-
Comparison of elderly people's technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial.
BMJ (Clinical research ed.) 20010310
-
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities.
Antimicrobial agents and chemotherapy 20010301
-
Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza.
Clinical therapeutics 20010301
-
Position statement: global neuraminidase inhibitor susceptibility network.
Antiviral research 20010301
-
Does the availability of a neuraminidase inhibitor impair influenza vaccination? A report from Austria.
Vaccine 20010227
-
The failings of NICE. Latest decision on zanamivir will not end postcode prescribing.
BMJ (Clinical research ed.) 20010224
-
The failings of NICE. 'Spinning' is not nice.
BMJ (Clinical research ed.) 20010224
-
Zanamivir to prevent influenza.
The New England journal of medicine 20010215
-
Zanamivir to prevent influenza.
The New England journal of medicine 20010215
-
[New preparations against influenza].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20010210
-
Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.
Canada communicable disease report = Releve des maladies transmissibles au Canada 20010201
-
Why not [symbol: see text]zanamivir?
Drug and therapeutics bulletin 20010201
-
[Efficacy of inhaled zanamivir in the treatment and prevention of influenza].
Anales de medicina interna (Madrid, Spain : 1984) 20010201
-
Zanamivir for the treatment of influenza A and B infection in high-risk patients: a pooled analysis of randomized controlled trials.
Archives of internal medicine 20010122
-
Neuraminidase inhibitors: zanamivir and oseltamivir.
The Annals of pharmacotherapy 20010101
-
Prophylactic and symptomatic treatment of influenza. Current and developing options.
Postgraduate medicine 20010101
-
[What is current opinion of antiviral therapy for the flu in 2001?].
La Revue de medecine interne 20010101
-
Zanamivir: a rational approach to influenza B.
Scandinavian journal of infectious diseases 20010101
-
Oseltamivir: a review of its use in influenza.
Drugs 20010101
-
Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients.
PharmacoEconomics 20010101
-
Prophylaxis and treatment of influenza virus infection.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20010101
-
Impact of patient characteristics on the risk of influenza/ILI-related complications.
BMC health services research 20010101
-
Antiviral drugs with extra-cellular sites of action.
Reviews in medical virology 20010101
-
Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications.
Drug safety 20010101
-
The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
Journal of virology 20001201
-
In vitro and in vivo assay systems for study of influenza virus inhibitors.
Antiviral research 20001001
-
BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design.
Journal of medicinal chemistry 20000921
-
Chemoprophylaxis of influenza A virus infections, with single doses of zanamivir, demonstrates that zanamivir is cleared slowly from the respiratory tract.
Antimicrobial agents and chemotherapy 19991101
-
A novel approach to antiviral therapy for influenza.
The Journal of antimicrobial chemotherapy 19991101
-
Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain.
European journal of medicinal chemistry 19990101
-
Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice.
The Journal of infectious diseases 19981201
-
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.
Antimicrobial agents and chemotherapy 19981201
-
Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 1. Discovery, synthesis, biological activity, and structure-activity relationships of 4-guanidino- and 4-amino-4H-pyran-6-carboxamides.
Journal of medicinal chemistry 19980312
-
Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
Journal of medicinal chemistry 19980312
-
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.
Antimicrobial agents and chemotherapy 19980301
-
Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor.
Antiviral research 19980201
-
Anti-influenza virus activities of 4-substituted 2,4-dioxobutanoic acid inhibitors.
Antimicrobial agents and chemotherapy 19960501
-
A study of the active site of influenza virus sialidase: an approach to the rational design of novel anti-influenza drugs.
Journal of medicinal chemistry 19960119
-
Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid.
Virology 19951001
-
Inhibition of influenza virus replication in mice by GG167 (4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid) is consistent with extracellular activity of viral neuraminidase (sialidase).
Antimicrobial agents and chemotherapy 19941001
-
Inhibition of the growth of influenza viruses in vitro by 4-guanidino-2,4-dideoxy-N-acetylneuraminic acid.
Antiviral research 19940801
-
4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro.
Antimicrobial agents and chemotherapy 19930701
-
Rational design of potent sialidase-based inhibitors of influenza virus replication.
Nature 19930603
-
Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid.
Virology 19740401